data_1ckx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ckx _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.566 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 121.53 0.681 . . . . 0.0 109.181 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.566 ' N ' ' CG2' ' A' ' 4' ' ' THR . 26.7 mm -67.27 -47.19 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.541 -0.725 . . . . 0.0 109.879 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 5' ' ' ILE . 30.1 tptt -45.19 -34.95 3.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.931 . . . . 0.0 109.058 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 11' ' ' PHE . 1.7 mt-10 -67.02 -47.46 71.35 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.398 -0.814 . . . . 0.0 108.815 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -55.51 -17.46 5.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.254 -0.904 . . . . 0.0 109.224 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 5' ' ' ILE . 6.5 mm -89.51 -14.34 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 109.226 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.457 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -114.66 -38.82 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.7 OUTLIER -52.61 -33.54 46.82 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.23 179.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.08 -41.11 40.82 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 76.2 t -59.07 -18.56 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.526 -0.985 . . . . 0.0 108.689 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 t -98.25 -52.19 3.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.486 -0.759 . . . . 0.0 109.227 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.564 ' CE2' ' HD2' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -60.42 -52.35 65.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.283 -0.885 . . . . 0.0 109.034 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 3.5 m-20 -49.46 -25.13 2.39 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -87.74 -22.82 24.37 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 15' ' ' TYR . 7.4 m-85 -89.08 -27.83 20.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 109.498 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.564 ' HD2' ' CE2' ' A' ' 15' ' ' TYR . 32.8 mtp180 -95.74 -4.32 44.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.257 -0.902 . . . . 0.0 109.556 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.401 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 44.5 t80 -89.96 -40.46 12.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.55 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.69 -26.52 62.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.153 -0.967 . . . . 0.0 109.627 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.5 t -70.33 -58.89 3.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.393 -0.817 . . . . 0.0 109.926 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 90.2 t . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.233 -0.917 . . . . 0.0 110.113 -179.517 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.491 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.491 ' N ' ' CG2' ' A' ' 4' ' ' THR . 24.5 mt -49.89 -34.25 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.42 -0.8 . . . . 0.0 109.644 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -83.19 -24.44 32.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.629 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 11' ' ' PHE . 1.5 mm-40 -86.47 -47.16 9.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.934 . . . . 0.0 109.546 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -58.01 -14.1 5.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.224 -0.922 . . . . 0.0 109.669 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.478 HD12 HG22 ' A' ' 9' ' ' ILE . 33.1 mt -103.48 -7.17 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.855 . . . . 0.0 109.683 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.519 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -120.84 -45.81 2.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.519 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -45.85 -36.32 5.18 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.32 -49.07 9.76 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 41.2 t -60.88 -40.09 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.424 -1.045 . . . . 0.0 109.015 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -57.84 -52.03 67.17 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.302 -0.874 . . . . 0.0 108.865 179.713 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.17 -55.21 27.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.417 -0.802 . . . . 0.0 108.85 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 20' ' ' TYR . 0.8 OUTLIER -51.35 -23.4 3.66 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.09 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 5.3 tt0 -97.95 -22.24 16.42 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.636 -0.665 . . . . 0.0 109.26 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -76.16 -30.72 58.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.098 -1.001 . . . . 0.0 109.455 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -106.26 10.7 31.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.335 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.415 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 72.8 t80 -119.57 -40.77 2.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.449 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.2 -42.33 55.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 109.5 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.5 t -52.44 -34.0 46.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.368 -0.832 . . . . 0.0 109.709 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 109.578 -179.908 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.489 HG21 ' N ' ' A' ' 5' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.489 ' N ' HG21 ' A' ' 4' ' ' THR . 3.6 mt -88.35 -53.63 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.347 -0.846 . . . . 0.0 109.204 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 tmmt? -46.01 -25.57 0.58 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 109.482 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 11' ' ' PHE . 1.6 mm-40 -97.25 -47.99 5.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.902 . . . . 0.0 109.314 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -54.52 -17.91 3.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.371 -0.831 . . . . 0.0 109.434 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 5' ' ' ILE . 4.1 mm -103.73 -7.51 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -0.854 . . . . 0.0 109.652 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.554 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -122.72 -49.72 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.554 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.9 OUTLIER -48.48 -32.91 8.51 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.14 -46.86 8.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.453 ' O ' HG11 ' A' ' 13' ' ' VAL . 85.8 t -57.28 -26.84 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -1.151 . . . . 0.0 109.156 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.5 t -79.02 -54.22 6.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.295 -0.878 . . . . 0.0 109.389 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.503 ' O ' ' N ' ' A' ' 18' ' ' TYR . 1.6 t80 -59.24 -55.04 39.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 108.782 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 15' ' ' TYR . 10.0 t0 -46.41 -26.66 0.88 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.35 -22.96 18.01 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.48 -0.763 . . . . 0.0 109.146 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 15' ' ' TYR . 0.6 OUTLIER -81.82 -25.83 34.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 109.543 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.23 -7.27 24.86 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.182 -0.949 . . . . 0.0 109.505 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.452 ' O ' HG11 ' A' ' 23' ' ' VAL . 58.8 t80 -106.4 -29.34 9.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.694 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -90.54 -44.93 9.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.045 -1.034 . . . . 0.0 109.537 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.5 t -49.5 -21.4 0.94 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.383 -0.823 . . . . 0.0 109.864 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.452 HG11 ' O ' ' A' ' 20' ' ' TYR . 11.5 p . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.107 -0.995 . . . . 0.0 109.77 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.418 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.475 HG21 HD13 ' A' ' 9' ' ' ILE . 3.5 mt -58.23 -50.7 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.595 -0.69 . . . . 0.0 109.616 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -51.61 -24.71 5.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 109.533 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 11' ' ' PHE . 0.9 OUTLIER -92.05 -47.92 7.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 109.685 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -63.22 -11.88 24.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.197 -0.939 . . . . 0.0 109.346 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.475 HD13 HG21 ' A' ' 5' ' ' ILE . 14.2 mt -100.88 -12.42 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 109.512 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.596 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -108.87 -50.75 7.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.596 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -47.08 -38.94 12.12 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.848 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.478 ' N ' ' CD1' ' A' ' 11' ' ' PHE . . . -70.28 -38.07 71.26 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.0 t -63.71 -45.67 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.232 -1.158 . . . . 0.0 109.041 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.9 t -54.61 -35.38 63.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.907 . . . . 0.0 109.125 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.489 ' O ' ' N ' ' A' ' 18' ' ' TYR . 2.4 t80 -71.83 -62.06 1.56 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.385 -0.822 . . . . 0.0 109.206 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 15' ' ' TYR . 74.6 m-20 -46.0 -26.61 0.75 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.213 -0.93 . . . . 0.0 108.623 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.82 -22.34 18.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.436 -0.79 . . . . 0.0 109.206 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.489 ' N ' ' O ' ' A' ' 15' ' ' TYR . 47.1 t80 -83.75 -52.3 6.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.953 . . . . 0.0 109.446 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.88 -37.07 80.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.106 -0.996 . . . . 0.0 109.22 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -59.34 -33.66 71.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.308 -0.87 . . . . 0.0 109.308 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.41 -28.3 66.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.621 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.6 t -83.57 -17.15 42.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 109.44 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 109.283 179.92 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.454 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.472 ' O ' HG12 ' A' ' 9' ' ' ILE . 31.0 mm -68.8 -45.39 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.331 -0.856 . . . . 0.0 109.516 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -46.06 -34.38 4.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.143 -0.973 . . . . 0.0 108.797 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 11' ' ' PHE . 7.7 mm-40 -68.88 -59.08 3.31 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.376 -0.827 . . . . 0.0 109.116 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -54.89 -19.24 6.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 0.0 109.422 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 5' ' ' ILE . 4.2 mm -93.67 -10.88 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 109.452 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.476 HG21 ' N ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -113.83 -39.04 2.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 179.561 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.476 ' N ' HG21 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -58.08 -30.42 66.22 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.834 179.381 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.69 -45.02 29.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.446 -1.862 . . . . 0.0 108.446 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.7 t -54.15 -23.59 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.419 -1.048 . . . . 0.0 108.289 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 t -94.47 -45.61 7.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.574 ' CD2' ' HD2' ' A' ' 19' ' ' ARG . 1.9 t80 -65.33 -57.75 7.61 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -49.3 -24.73 1.97 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -91.04 -24.63 20.0 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.485 ' N ' ' O ' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -80.34 -43.96 20.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.333 -0.854 . . . . 0.0 109.448 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.574 ' HD2' ' CD2' ' A' ' 15' ' ' TYR . 4.1 mtt180 -67.65 -20.31 65.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 109.639 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -76.26 -31.09 58.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.144 -0.973 . . . . 0.0 109.717 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.16 -40.75 15.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.289 -0.882 . . . . 0.0 109.672 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -69.11 -32.92 72.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 109.851 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.152 -0.968 . . . . 0.0 109.747 -179.799 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.542 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.542 ' N ' ' CG2' ' A' ' 4' ' ' THR . 87.0 mt -83.07 -47.16 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.504 -0.747 . . . . 0.0 109.438 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -48.19 -37.53 15.99 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.183 -0.948 . . . . 0.0 109.046 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.517 ' HG3' ' N ' ' A' ' 8' ' ' ASN . 14.9 pt-20 -82.7 -37.36 24.87 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.352 -0.843 . . . . 0.0 109.069 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.517 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 26.4 t30 -68.6 -6.86 28.08 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.311 -0.868 . . . . 0.0 108.728 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.505 HD12 HG22 ' A' ' 9' ' ' ILE . 27.9 mt -104.65 -12.16 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.424 -0.798 . . . . 0.0 109.421 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.486 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.4 OUTLIER -107.49 -46.3 7.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.486 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -43.38 -31.32 0.65 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.48 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.15 -35.82 22.88 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 10' ' ' ILE . 60.0 t -79.6 -23.03 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.419 -1.048 . . . . 0.0 109.131 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.557 ' OG ' ' CZ ' ' A' ' 18' ' ' TYR . 1.1 t -85.98 -41.46 14.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.252 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 18' ' ' TYR . 2.2 t80 -61.2 -56.78 16.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.24 -0.912 . . . . 0.0 108.585 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -49.5 -24.8 2.23 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.43 -23.47 18.39 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.557 ' CZ ' ' OG ' ' A' ' 14' ' ' SER . 8.3 m-30 -76.32 -59.24 2.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 0.0 109.641 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -18.88 52.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.934 . . . . 0.0 109.444 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.471 ' O ' HG11 ' A' ' 23' ' ' VAL . 43.8 t80 -78.47 -60.34 2.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 109.217 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.3 tmm_? -48.91 -38.11 21.78 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.1 t -56.7 -41.36 77.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.457 -0.777 . . . . 0.0 109.744 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.471 HG11 ' O ' ' A' ' 20' ' ' TYR . 2.9 p . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.113 -0.992 . . . . 0.0 109.439 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.507 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.507 ' N ' ' CG2' ' A' ' 4' ' ' THR . 2.3 mp -57.45 -51.86 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.524 -0.735 . . . . 0.0 109.213 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -47.42 -36.27 9.61 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.553 ' O ' ' N ' ' A' ' 11' ' ' PHE . 3.1 mt-10 -69.57 -45.73 68.0 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -49.47 -21.36 0.91 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.124 -0.985 . . . . 0.0 108.92 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.1 mt -93.83 -13.78 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.204 -0.935 . . . . 0.0 109.86 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.53 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -124.85 -52.23 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.553 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.9 OUTLIER -47.31 -28.96 2.21 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.719 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.25 -34.58 29.09 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.443 ' O ' HG11 ' A' ' 13' ' ' VAL . 53.8 t -79.45 -26.13 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.488 -1.007 . . . . 0.0 109.027 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.4 OUTLIER -79.13 -30.69 43.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.446 -0.784 . . . . 0.0 109.161 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.425 ' HA ' ' HB3' ' A' ' 18' ' ' TYR . 2.4 t80 -69.76 -53.3 18.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.253 -0.905 . . . . 0.0 108.828 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.24 -26.47 11.87 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.14 -17.27 17.49 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 14' ' ' SER . 12.5 t80 -87.36 -55.73 3.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.379 -0.826 . . . . 0.0 109.391 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.425 ' HG3' ' CE2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -46.55 -25.75 0.75 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.253 -0.904 . . . . 0.0 109.05 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -85.54 -34.01 21.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.316 -0.865 . . . . 0.0 109.068 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' A' ' 18' ' ' TYR . 1.7 ttp180 -81.18 -22.93 38.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.943 . . . . 0.0 109.447 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.6 t -69.55 -25.13 63.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.323 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.364 -0.835 . . . . 0.0 109.406 179.984 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.34 -49.62 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.382 -0.824 . . . . 0.0 109.341 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -57.03 -37.0 71.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -0.876 . . . . 0.0 109.272 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 11' ' ' PHE . 5.1 mm-40 -61.66 -50.93 70.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.875 . . . . 0.0 109.145 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -51.15 -20.36 1.48 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.906 -1.121 . . . . 0.0 109.014 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.476 HD11 HG22 ' A' ' 9' ' ' ILE . 33.6 mt -108.1 -7.66 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 110.385 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -126.71 -41.25 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.084 -1.01 . . . . 0.0 108.51 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.542 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -47.72 -31.61 4.92 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.541 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.34 -44.31 6.63 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.412 ' O ' HG11 ' A' ' 13' ' ' VAL . 92.0 t -72.12 -21.0 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.431 -1.04 . . . . 0.0 108.929 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.57 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -82.5 -49.17 10.2 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.482 ' CZ ' ' HG3' ' A' ' 19' ' ' ARG . 4.7 t80 -52.94 -50.51 63.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 108.772 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -53.63 -19.72 4.33 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.44 ' O ' ' NH1' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -117.97 -0.12 11.75 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.329 -0.857 . . . . 0.0 109.536 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.57 ' N ' ' O ' ' A' ' 14' ' ' SER . 7.2 t80 -104.99 -59.19 1.78 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.105 -0.997 . . . . 0.0 109.948 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.482 ' HG3' ' CZ ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -49.75 -30.52 9.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.146 -0.971 . . . . 0.0 109.509 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -75.16 -48.75 22.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.492 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.44 ' NH1' ' O ' ' A' ' 17' ' ' GLU . 19.9 mtm-85 -71.03 -34.92 71.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.368 -0.833 . . . . 0.0 109.525 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.2 t -59.09 -15.35 13.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.192 -0.942 . . . . 0.0 109.467 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.473 179.865 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.443 0.639 . . . . 0.0 109.316 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.498 ' O ' HG12 ' A' ' 9' ' ' ILE . 4.0 mt -56.17 -52.6 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.318 -0.864 . . . . 0.0 109.622 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.471 ' HG3' ' HG2' ' A' ' 7' ' ' GLU . 12.8 pttm -43.76 -28.87 0.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.417 -0.802 . . . . 0.0 109.525 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.471 ' HG2' ' HG3' ' A' ' 6' ' ' LYS . 3.9 mm-40 -85.58 -49.43 8.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.44 -0.787 . . . . 0.0 109.704 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -59.64 -14.29 13.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 0.0 109.657 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 5' ' ' ILE . 14.6 mm -91.71 -15.27 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 109.283 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.549 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -115.21 -55.82 4.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.549 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.1 OUTLIER -46.8 -28.17 1.46 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.385 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 16' ' ' ASP . . . -75.57 -45.21 18.68 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 58.1 t -54.37 -20.27 4.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.561 -0.964 . . . . 0.0 108.548 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 0.4 OUTLIER -103.17 -51.23 3.29 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.71 -0.619 . . . . 0.0 109.482 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.454 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.3 OUTLIER -72.02 -60.31 2.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -0.928 . . . . 0.0 109.439 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.54 ' O ' ' CB ' ' A' ' 20' ' ' TYR . 4.2 m-20 -50.39 -21.83 1.6 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.047 -1.033 . . . . 0.0 108.485 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -96.29 -17.37 20.77 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.383 -0.823 . . . . 0.0 109.266 179.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 14' ' ' SER . 1.1 m-85 -99.05 -41.75 7.41 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.192 -0.943 . . . . 0.0 110.68 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.2 -4.35 54.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.009 -1.057 . . . . 0.0 110.426 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.54 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 22.7 t80 -95.42 -72.72 0.61 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.997 -1.064 . . . . 0.0 109.656 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.02 -31.3 2.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.278 -0.889 . . . . 0.0 109.325 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.4 t -61.83 -14.81 36.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.37 -0.832 . . . . 0.0 109.883 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.154 -0.966 . . . . 0.0 109.732 -179.86 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.47 ' O ' ' HG2' ' A' ' 7' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 69.4 mt -83.11 -44.47 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.457 -0.777 . . . . 0.0 109.526 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -46.71 -34.5 5.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.873 . . . . 0.0 109.214 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 11' ' ' PHE . 13.2 pt-20 -86.12 -39.87 16.27 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.3 -0.875 . . . . 0.0 108.728 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.523 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 7.2 t-20 -54.29 -17.72 3.24 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.975 -1.078 . . . . 0.0 108.202 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.404 ' N ' ' C ' ' A' ' 7' ' ' GLU . 6.8 mm -98.23 -15.5 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.47 -0.769 . . . . 0.0 109.602 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.577 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -121.96 -52.32 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.577 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 1.6 t80 -51.63 -28.1 13.36 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.64 -38.89 13.01 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.1 t -71.64 -32.51 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -1.103 . . . . 0.0 108.832 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 18' ' ' TYR . 8.2 t -66.38 -39.11 88.89 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.265 -0.897 . . . . 0.0 108.899 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.454 ' O ' ' N ' ' A' ' 18' ' ' TYR . 2.4 t80 -62.25 -55.14 31.32 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.289 -0.882 . . . . 0.0 108.817 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 15' ' ' TYR . 93.5 m-20 -46.73 -30.77 2.56 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -90.17 -27.89 19.27 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.456 ' N ' ' O ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -72.44 -37.56 68.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.315 -0.866 . . . . 0.0 109.011 179.6 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.497 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 4.1 mtm180 -77.01 -44.13 32.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.063 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.547 ' CD1' ' C ' ' A' ' 20' ' ' TYR . 6.2 t80 -49.48 -26.25 3.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.363 -0.836 . . . . 0.0 108.984 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -77.61 -51.6 10.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.375 -0.828 . . . . 0.0 109.236 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -67.25 -12.99 61.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.881 . . . . 0.0 109.305 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.497 ' CG2' ' O ' ' A' ' 19' ' ' ARG . 14.3 t . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.218 -0.926 . . . . 0.0 109.612 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.472 HG21 ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.472 ' N ' HG21 ' A' ' 4' ' ' THR . 42.1 mm -47.75 -37.12 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.443 -0.786 . . . . 0.0 109.147 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -77.25 -52.31 9.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.378 -0.826 . . . . 0.0 109.142 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 11' ' ' PHE . 1.1 mm-40 -59.29 -42.88 92.31 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.271 -0.893 . . . . 0.0 109.043 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -46.6 -23.82 0.45 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.068 -1.02 . . . . 0.0 109.275 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 5' ' ' ILE . 4.1 mm -97.57 -15.74 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.827 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.4 OUTLIER -120.55 -52.11 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.106 -0.996 . . . . 0.0 108.589 179.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.573 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -42.17 -32.36 0.47 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.6 -45.3 13.76 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.87 -32.02 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.436 -1.038 . . . . 0.0 108.824 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.5 -32.56 54.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.405 -0.809 . . . . 0.0 109.018 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -62.48 -53.31 56.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -0.846 . . . . 0.0 108.861 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.0 -22.87 2.52 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -99.39 -17.17 18.13 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.466 -0.771 . . . . 0.0 109.267 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.93 -54.07 4.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 0.0 109.829 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.482 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -56.73 -25.26 54.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 110.02 -179.553 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -68.95 -45.0 71.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.188 -0.945 . . . . 0.0 109.957 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.17 -33.47 67.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.92 . . . . 0.0 109.834 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.7 t -74.67 -4.49 37.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 0.0 110.163 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' A' ' 19' ' ' ARG . 61.3 t . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.04 -1.037 . . . . 0.0 110.078 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.556 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.412 0.625 . . . . 0.0 109.395 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.556 ' N ' ' CG2' ' A' ' 4' ' ' THR . 22.2 mm -53.89 -40.02 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.431 -0.793 . . . . 0.0 109.655 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -61.82 -51.51 67.96 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.367 -0.833 . . . . 0.0 109.424 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.58 ' HG3' ' N ' ' A' ' 8' ' ' ASN . 0.8 OUTLIER -64.2 -29.74 70.83 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.192 -0.943 . . . . 0.0 109.175 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.58 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 1.8 t30 -63.57 -11.29 23.4 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.718 -1.238 . . . . 0.0 108.229 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.501 HD11 HG22 ' A' ' 9' ' ' ILE . 39.6 mt -109.02 -8.65 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.462 -0.774 . . . . 0.0 109.861 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.4 OUTLIER -124.37 -42.99 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.555 ' N ' ' O ' ' A' ' 7' ' ' GLU . 13.8 t80 -45.11 -32.55 1.81 Allowed 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.029 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.82 -49.96 4.86 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.63 -35.23 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -1.179 . . . . 0.0 108.941 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -65.05 -45.47 85.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.359 -0.838 . . . . 0.0 109.113 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.474 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -57.64 -53.12 61.74 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.394 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 15' ' ' TYR . 1.5 m-20 -45.69 -30.8 1.68 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.01 -26.9 18.15 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.474 ' N ' ' O ' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -69.83 -44.7 69.42 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.454 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -69.06 -28.52 66.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 0.0 109.286 179.782 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -75.13 -12.02 60.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.3 -0.875 . . . . 0.0 109.324 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -100.85 -45.03 5.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.845 . . . . 0.0 109.432 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.0 t -71.77 -37.62 70.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 0.0 109.47 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 19' ' ' ARG . 73.1 t . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.329 -0.857 . . . . 0.0 109.459 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.446 HG21 ' N ' ' A' ' 5' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.469 ' O ' HG13 ' A' ' 9' ' ' ILE . 34.2 mm -55.7 -46.89 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.312 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.42 ' HG3' ' N ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -60.99 -36.51 79.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.361 -0.837 . . . . 0.0 109.207 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 11' ' ' PHE . 2.1 mm-40 -70.17 -50.46 40.07 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.893 . . . . 0.0 108.963 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -48.16 -23.11 0.76 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 109.47 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 5' ' ' ILE . 18.2 mt -91.97 -13.36 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.302 -0.874 . . . . 0.0 109.866 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.55 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -119.07 -49.59 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.55 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -43.86 -36.28 2.3 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.57 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.99 -54.97 8.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.95 -47.34 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -61.6 -24.65 66.83 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.488 ' O ' ' N ' ' A' ' 18' ' ' TYR . 11.6 t80 -61.17 -57.72 11.29 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 15' ' ' TYR . 44.7 m-20 -45.36 -28.67 0.89 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -94.73 -26.18 16.38 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.526 ' N ' ' O ' ' A' ' 14' ' ' SER . 9.9 t80 -76.38 -41.22 48.73 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -45.6 -37.8 5.93 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.235 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 20' ' ' TYR . 1.5 t80 -68.49 -42.97 77.88 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -67.99 -27.44 66.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.452 -0.78 . . . . 0.0 109.362 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.4 t -79.87 -44.54 20.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.404 -0.81 . . . . 0.0 109.865 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 42.1 t . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.145 -0.972 . . . . 0.0 109.606 -179.688 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.5 72.36 3.65 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.881 1.463 . . . . 0.0 110.449 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -127.87 25.92 4.89 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.566 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -56.83 -49.51 75.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.353 -1.086 . . . . 0.0 109.181 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.566 ' N ' ' CG2' ' A' ' 4' ' ' THR . 26.7 mm -67.27 -47.19 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.541 -0.725 . . . . 0.0 109.879 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 5' ' ' ILE . 30.1 tptt -45.19 -34.95 3.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.931 . . . . 0.0 109.058 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 11' ' ' PHE . 1.7 mt-10 -67.02 -47.46 71.35 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.398 -0.814 . . . . 0.0 108.815 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -55.51 -17.46 5.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.254 -0.904 . . . . 0.0 109.224 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 5' ' ' ILE . 6.5 mm -89.51 -14.34 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 109.226 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.457 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -114.66 -38.82 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.7 OUTLIER -52.61 -33.54 46.82 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.23 179.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.08 -41.11 40.82 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 76.2 t -59.07 -18.56 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.526 -0.985 . . . . 0.0 108.689 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 t -98.25 -52.19 3.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.486 -0.759 . . . . 0.0 109.227 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.564 ' CE2' ' HD2' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -60.42 -52.35 65.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.283 -0.885 . . . . 0.0 109.034 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 3.5 m-20 -49.46 -25.13 2.39 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -87.74 -22.82 24.37 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 15' ' ' TYR . 7.4 m-85 -89.08 -27.83 20.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 109.498 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.564 ' HD2' ' CE2' ' A' ' 15' ' ' TYR . 32.8 mtp180 -95.74 -4.32 44.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.257 -0.902 . . . . 0.0 109.556 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.463 ' O ' HD11 ' A' ' 24' ' ' ILE . 44.5 t80 -89.96 -40.46 12.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.55 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.69 -26.52 62.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.153 -0.967 . . . . 0.0 109.627 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.5 t -70.33 -58.89 3.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.393 -0.817 . . . . 0.0 109.926 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 90.2 t -58.49 -35.23 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.233 -0.917 . . . . 0.0 110.113 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.585 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 1.7 mp -98.41 16.69 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.138 -0.976 . . . . 0.0 109.378 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -64.95 107.48 1.5 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.053 -1.029 . . . . 0.0 109.638 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 25' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.585 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.778 0.323 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -75.57 70.36 5.7 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.103 1.581 . . . . 0.0 110.424 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -127.68 14.9 6.35 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.491 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -62.66 -46.54 87.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -1.145 . . . . 0.0 109.299 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.491 ' N ' ' CG2' ' A' ' 4' ' ' THR . 24.5 mt -49.89 -34.25 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.42 -0.8 . . . . 0.0 109.644 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -83.19 -24.44 32.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.629 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 11' ' ' PHE . 1.5 mm-40 -86.47 -47.16 9.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.934 . . . . 0.0 109.546 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -58.01 -14.1 5.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.224 -0.922 . . . . 0.0 109.669 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.478 HD12 HG22 ' A' ' 9' ' ' ILE . 33.1 mt -103.48 -7.17 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.855 . . . . 0.0 109.683 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.519 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -120.84 -45.81 2.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.519 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -45.85 -36.32 5.18 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.32 -49.07 9.76 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 41.2 t -60.88 -40.09 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.424 -1.045 . . . . 0.0 109.015 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -57.84 -52.03 67.17 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.302 -0.874 . . . . 0.0 108.865 179.713 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.17 -55.21 27.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.417 -0.802 . . . . 0.0 108.85 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 20' ' ' TYR . 0.8 OUTLIER -51.35 -23.4 3.66 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.09 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 5.3 tt0 -97.95 -22.24 16.42 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.636 -0.665 . . . . 0.0 109.26 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -76.16 -30.72 58.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.098 -1.001 . . . . 0.0 109.455 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -106.26 10.7 31.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.335 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.553 ' CE2' HG23 ' A' ' 24' ' ' ILE . 72.8 t80 -119.57 -40.77 2.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.449 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.515 ' O ' ' N ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -75.2 -42.33 55.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 109.5 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.5 t -52.44 -34.0 46.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.368 -0.832 . . . . 0.0 109.709 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.519 HG12 ' N ' ' A' ' 24' ' ' ILE . 8.7 p -92.98 -41.08 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 109.578 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.553 HG23 ' CE2' ' A' ' 20' ' ' TYR . 1.5 tp -88.56 11.22 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.346 -0.846 . . . . 0.0 109.985 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 21' ' ' ARG . 0.4 OUTLIER -64.21 -170.14 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.007 -1.058 . . . . 0.0 109.136 179.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 25' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.643 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.723 0.297 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.25 165.1 33.52 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.057 1.556 . . . . 0.0 110.552 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 117.0 27.4 2.72 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.489 HG21 ' N ' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -116.63 -44.73 2.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.363 -1.081 . . . . 0.0 108.913 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.489 ' N ' HG21 ' A' ' 4' ' ' THR . 3.6 mt -88.35 -53.63 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.347 -0.846 . . . . 0.0 109.204 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 tmmt? -46.01 -25.57 0.58 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 109.482 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 11' ' ' PHE . 1.6 mm-40 -97.25 -47.99 5.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.902 . . . . 0.0 109.314 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -54.52 -17.91 3.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.371 -0.831 . . . . 0.0 109.434 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 5' ' ' ILE . 4.1 mm -103.73 -7.51 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -0.854 . . . . 0.0 109.652 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.554 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -122.72 -49.72 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.554 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.9 OUTLIER -48.48 -32.91 8.51 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.14 -46.86 8.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.453 ' O ' HG11 ' A' ' 13' ' ' VAL . 85.8 t -57.28 -26.84 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -1.151 . . . . 0.0 109.156 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.5 t -79.02 -54.22 6.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.295 -0.878 . . . . 0.0 109.389 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.503 ' O ' ' N ' ' A' ' 18' ' ' TYR . 1.6 t80 -59.24 -55.04 39.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 108.782 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 15' ' ' TYR . 10.0 t0 -46.41 -26.66 0.88 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.35 -22.96 18.01 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.48 -0.763 . . . . 0.0 109.146 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 15' ' ' TYR . 0.6 OUTLIER -81.82 -25.83 34.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 109.543 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.23 -7.27 24.86 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.182 -0.949 . . . . 0.0 109.505 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.475 ' O ' HG12 ' A' ' 24' ' ' ILE . 58.8 t80 -106.4 -29.34 9.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.694 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -90.54 -44.93 9.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.045 -1.034 . . . . 0.0 109.537 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.5 t -49.5 -21.4 0.94 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.383 -0.823 . . . . 0.0 109.864 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 24' ' ' ILE . 11.5 p -92.63 -42.83 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.107 -0.995 . . . . 0.0 109.77 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.501 ' N ' HG12 ' A' ' 23' ' ' VAL . 22.9 mm -76.66 -26.78 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.222 -0.923 . . . . 0.0 109.77 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 26' ' ' ALA . 22.7 tttt -57.79 -54.98 40.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.152 -0.968 . . . . 0.0 109.425 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 25' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.48 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.816 0.341 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.64 -168.02 0.37 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.988 1.52 . . . . 0.0 110.323 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 99.25 -19.13 55.25 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.418 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -81.92 -42.05 20.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -1.144 . . . . 0.0 109.037 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.475 HG21 HD13 ' A' ' 9' ' ' ILE . 3.5 mt -58.23 -50.7 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.595 -0.69 . . . . 0.0 109.616 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -51.61 -24.71 5.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 109.533 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 11' ' ' PHE . 0.9 OUTLIER -92.05 -47.92 7.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 109.685 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -63.22 -11.88 24.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.197 -0.939 . . . . 0.0 109.346 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.475 HD13 HG21 ' A' ' 5' ' ' ILE . 14.2 mt -100.88 -12.42 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 109.512 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.596 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -108.87 -50.75 7.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.596 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -47.08 -38.94 12.12 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.848 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.478 ' N ' ' CD1' ' A' ' 11' ' ' PHE . . . -70.28 -38.07 71.26 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.0 t -63.71 -45.67 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.232 -1.158 . . . . 0.0 109.041 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.9 t -54.61 -35.38 63.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.907 . . . . 0.0 109.125 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.489 ' O ' ' N ' ' A' ' 18' ' ' TYR . 2.4 t80 -71.83 -62.06 1.56 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.385 -0.822 . . . . 0.0 109.206 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 15' ' ' TYR . 74.6 m-20 -46.0 -26.61 0.75 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.213 -0.93 . . . . 0.0 108.623 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.82 -22.34 18.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.436 -0.79 . . . . 0.0 109.206 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.489 ' N ' ' O ' ' A' ' 15' ' ' TYR . 47.1 t80 -83.75 -52.3 6.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.953 . . . . 0.0 109.446 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.88 -37.07 80.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.106 -0.996 . . . . 0.0 109.22 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -59.34 -33.66 71.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.308 -0.87 . . . . 0.0 109.308 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.41 -28.3 66.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.621 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.6 t -83.57 -17.15 42.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 109.44 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.4 t -76.69 -34.44 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 109.283 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.513 ' N ' HD11 ' A' ' 24' ' ' ILE . 2.6 mp -104.95 -24.19 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.362 -0.836 . . . . 0.0 109.153 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.518 ' HG3' ' N ' ' A' ' 26' ' ' ALA . 7.8 tptt 40.81 -94.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.554 -0.716 . . . . 0.0 109.839 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.518 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.105 -0.997 . . . . 0.0 109.427 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 120.864 0.364 . . . . 0.0 110.094 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -78.14 169.07 20.92 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.131 1.595 . . . . 0.0 110.199 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 59.33 15.23 30.17 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.454 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -119.22 -48.05 2.44 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -1.121 . . . . 0.0 109.018 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.472 ' O ' HG12 ' A' ' 9' ' ' ILE . 31.0 mm -68.8 -45.39 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.331 -0.856 . . . . 0.0 109.516 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -46.06 -34.38 4.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.143 -0.973 . . . . 0.0 108.797 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 11' ' ' PHE . 7.7 mm-40 -68.88 -59.08 3.31 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.376 -0.827 . . . . 0.0 109.116 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -54.89 -19.24 6.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 0.0 109.422 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 5' ' ' ILE . 4.2 mm -93.67 -10.88 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 109.452 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.476 HG21 ' N ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -113.83 -39.04 2.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 179.561 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.476 ' N ' HG21 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -58.08 -30.42 66.22 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.834 179.381 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.69 -45.02 29.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.446 -1.862 . . . . 0.0 108.446 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.7 t -54.15 -23.59 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.419 -1.048 . . . . 0.0 108.289 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 t -94.47 -45.61 7.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.574 ' CD2' ' HD2' ' A' ' 19' ' ' ARG . 1.9 t80 -65.33 -57.75 7.61 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -49.3 -24.73 1.97 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -91.04 -24.63 20.0 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.485 ' N ' ' O ' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -80.34 -43.96 20.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.333 -0.854 . . . . 0.0 109.448 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.574 ' HD2' ' CD2' ' A' ' 15' ' ' TYR . 4.1 mtt180 -67.65 -20.31 65.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 109.639 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -76.26 -31.09 58.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.144 -0.973 . . . . 0.0 109.717 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.524 ' O ' ' CA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -86.16 -40.75 15.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.289 -0.882 . . . . 0.0 109.672 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -69.11 -32.92 72.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 109.851 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.523 HG12 ' CD1' ' A' ' 24' ' ' ILE . 7.6 p -74.13 -46.46 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.152 -0.968 . . . . 0.0 109.747 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.546 ' CG2' ' O ' ' A' ' 24' ' ' ILE . 3.4 mt -123.45 44.32 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 109.173 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.524 ' CA ' ' O ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -45.48 -29.41 1.13 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.253 -0.905 . . . . 0.0 109.578 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.481 -179.946 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mtt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 120.834 0.35 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.95 -174.66 1.61 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.059 1.557 . . . . 0.0 110.51 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 88.93 54.28 2.36 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.542 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -108.33 -49.43 3.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.314 -1.109 . . . . 0.0 109.058 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.542 ' N ' ' CG2' ' A' ' 4' ' ' THR . 87.0 mt -83.07 -47.16 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.504 -0.747 . . . . 0.0 109.438 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -48.19 -37.53 15.99 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.183 -0.948 . . . . 0.0 109.046 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.517 ' HG3' ' N ' ' A' ' 8' ' ' ASN . 14.9 pt-20 -82.7 -37.36 24.87 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.352 -0.843 . . . . 0.0 109.069 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.517 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 26.4 t30 -68.6 -6.86 28.08 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.311 -0.868 . . . . 0.0 108.728 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.505 HD12 HG22 ' A' ' 9' ' ' ILE . 27.9 mt -104.65 -12.16 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.424 -0.798 . . . . 0.0 109.421 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.486 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.4 OUTLIER -107.49 -46.3 7.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.486 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -43.38 -31.32 0.65 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.48 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.15 -35.82 22.88 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 10' ' ' ILE . 60.0 t -79.6 -23.03 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.419 -1.048 . . . . 0.0 109.131 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.557 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 1.1 t -85.98 -41.46 14.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.252 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 18' ' ' TYR . 2.2 t80 -61.2 -56.78 16.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.24 -0.912 . . . . 0.0 108.585 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -49.5 -24.8 2.23 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.43 -23.47 18.39 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.557 ' CD1' ' O ' ' A' ' 14' ' ' SER . 8.3 m-30 -76.32 -59.24 2.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 0.0 109.641 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -18.88 52.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.934 . . . . 0.0 109.444 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.471 ' O ' HG11 ' A' ' 23' ' ' VAL . 43.8 t80 -78.47 -60.34 2.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 109.217 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.3 tmm_? -48.91 -38.11 21.78 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.1 t -56.7 -41.36 77.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.457 -0.777 . . . . 0.0 109.744 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.521 HG11 ' N ' ' A' ' 24' ' ' ILE . 2.9 p -72.05 -27.46 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.113 -0.992 . . . . 0.0 109.439 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.521 ' N ' HG11 ' A' ' 23' ' ' VAL . 8.9 mm -91.58 2.47 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.386 -0.821 . . . . 0.0 109.536 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.99 -47.7 9.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 109.526 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.387 -179.891 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.873 0.368 . . . . 0.0 110.324 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.5 164.82 34.03 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.006 1.53 . . . . 0.0 110.402 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.8 44.06 21.06 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.507 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -121.92 -47.17 2.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.306 -1.114 . . . . 0.0 109.229 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.507 ' N ' ' CG2' ' A' ' 4' ' ' THR . 2.3 mp -57.45 -51.86 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.524 -0.735 . . . . 0.0 109.213 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -47.42 -36.27 9.61 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.553 ' O ' ' N ' ' A' ' 11' ' ' PHE . 3.1 mt-10 -69.57 -45.73 68.0 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -49.47 -21.36 0.91 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.124 -0.985 . . . . 0.0 108.92 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.1 mt -93.83 -13.78 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.204 -0.935 . . . . 0.0 109.86 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.53 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -124.85 -52.23 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.553 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.9 OUTLIER -47.31 -28.96 2.21 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.719 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.25 -34.58 29.09 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.443 ' O ' HG11 ' A' ' 13' ' ' VAL . 53.8 t -79.45 -26.13 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.488 -1.007 . . . . 0.0 109.027 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.4 OUTLIER -79.13 -30.69 43.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.446 -0.784 . . . . 0.0 109.161 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.425 ' HA ' ' HB3' ' A' ' 18' ' ' TYR . 2.4 t80 -69.76 -53.3 18.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.253 -0.905 . . . . 0.0 108.828 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.24 -26.47 11.87 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.14 -17.27 17.49 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 14' ' ' SER . 12.5 t80 -87.36 -55.73 3.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.379 -0.826 . . . . 0.0 109.391 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.425 ' HG3' ' CE2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -46.55 -25.75 0.75 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.253 -0.904 . . . . 0.0 109.05 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -85.54 -34.01 21.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.316 -0.865 . . . . 0.0 109.068 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 25' ' ' LYS . 1.7 ttp180 -81.18 -22.93 38.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.943 . . . . 0.0 109.447 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.6 t -69.55 -25.13 63.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.323 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.8 t -88.12 -18.99 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.364 -0.835 . . . . 0.0 109.406 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.515 ' CG2' ' O ' ' A' ' 24' ' ' ILE . 4.5 mp -142.8 38.61 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.409 -0.807 . . . . 0.0 109.448 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 21' ' ' ARG . 59.4 tttm -54.0 -71.93 0.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.16 -0.963 . . . . 0.0 109.448 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.099 -0.953 . . . . 0.0 109.507 179.935 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mtm . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 120.749 0.309 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.86 63.03 4.89 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.903 1.475 . . . . 0.0 110.597 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -132.97 35.13 2.35 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.57 -37.39 9.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -1.076 . . . . 0.0 109.237 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.34 -49.62 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.382 -0.824 . . . . 0.0 109.341 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -57.03 -37.0 71.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -0.876 . . . . 0.0 109.272 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 11' ' ' PHE . 5.1 mm-40 -61.66 -50.93 70.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.875 . . . . 0.0 109.145 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -51.15 -20.36 1.48 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.906 -1.121 . . . . 0.0 109.014 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.476 HD11 HG22 ' A' ' 9' ' ' ILE . 33.6 mt -108.1 -7.66 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 110.385 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -126.71 -41.25 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.084 -1.01 . . . . 0.0 108.51 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.542 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -47.72 -31.61 4.92 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.541 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.34 -44.31 6.63 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.412 ' O ' HG11 ' A' ' 13' ' ' VAL . 92.0 t -72.12 -21.0 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.431 -1.04 . . . . 0.0 108.929 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.57 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -82.5 -49.17 10.2 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.482 ' CZ ' ' HG3' ' A' ' 19' ' ' ARG . 4.7 t80 -52.94 -50.51 63.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 108.772 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -53.63 -19.72 4.33 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.44 ' O ' ' NH1' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -117.97 -0.12 11.75 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.329 -0.857 . . . . 0.0 109.536 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.57 ' N ' ' O ' ' A' ' 14' ' ' SER . 7.2 t80 -104.99 -59.19 1.78 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.105 -0.997 . . . . 0.0 109.948 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.482 ' HG3' ' CZ ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -49.75 -30.52 9.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.146 -0.971 . . . . 0.0 109.509 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -75.16 -48.75 22.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.492 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 25' ' ' LYS . 19.9 mtm-85 -71.03 -34.92 71.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.368 -0.833 . . . . 0.0 109.525 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.2 t -59.09 -15.35 13.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.192 -0.942 . . . . 0.0 109.467 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.413 HG13 HD13 ' A' ' 24' ' ' ILE . 48.9 t -98.58 -40.83 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.473 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.413 HD13 HG13 ' A' ' 23' ' ' VAL . 3.8 mp -123.74 36.53 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.794 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 21' ' ' ARG . 7.3 tttt -58.61 112.55 1.65 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.167 -0.958 . . . . 0.0 109.41 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.38 179.905 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttm . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 120.892 0.377 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.43 172.64 15.27 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.109 1.584 . . . . 0.0 110.531 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 53.08 32.27 42.35 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.94 -36.41 0.61 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.335 -1.097 . . . . 0.0 109.316 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.498 ' O ' HG12 ' A' ' 9' ' ' ILE . 4.0 mt -56.17 -52.6 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.318 -0.864 . . . . 0.0 109.622 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.471 ' HG3' ' HG2' ' A' ' 7' ' ' GLU . 12.8 pttm -43.76 -28.87 0.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.417 -0.802 . . . . 0.0 109.525 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.471 ' HG2' ' HG3' ' A' ' 6' ' ' LYS . 3.9 mm-40 -85.58 -49.43 8.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.44 -0.787 . . . . 0.0 109.704 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -59.64 -14.29 13.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 0.0 109.657 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 5' ' ' ILE . 14.6 mm -91.71 -15.27 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 109.283 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.549 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -115.21 -55.82 4.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.549 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.1 OUTLIER -46.8 -28.17 1.46 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.385 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 16' ' ' ASP . . . -75.57 -45.21 18.68 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 58.1 t -54.37 -20.27 4.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.561 -0.964 . . . . 0.0 108.548 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 0.4 OUTLIER -103.17 -51.23 3.29 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.71 -0.619 . . . . 0.0 109.482 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.454 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.3 OUTLIER -72.02 -60.31 2.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -0.928 . . . . 0.0 109.439 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.54 ' O ' ' CB ' ' A' ' 20' ' ' TYR . 4.2 m-20 -50.39 -21.83 1.6 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.047 -1.033 . . . . 0.0 108.485 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -96.29 -17.37 20.77 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.383 -0.823 . . . . 0.0 109.266 179.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 14' ' ' SER . 1.1 m-85 -99.05 -41.75 7.41 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.192 -0.943 . . . . 0.0 110.68 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.2 -4.35 54.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.009 -1.057 . . . . 0.0 110.426 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.54 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 22.7 t80 -95.42 -72.72 0.61 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.997 -1.064 . . . . 0.0 109.656 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -46.02 -31.3 2.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.278 -0.889 . . . . 0.0 109.325 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.4 t -61.83 -14.81 36.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.37 -0.832 . . . . 0.0 109.883 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 t -114.18 -21.81 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.154 -0.966 . . . . 0.0 109.732 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.584 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 1.5 mp -97.09 -29.51 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 0.0 109.703 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -143.91 139.11 29.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.176 -0.952 . . . . 0.0 109.717 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.388 179.867 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 mtt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.79 153.84 43.15 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.865 1.455 . . . . 0.0 110.391 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 55.39 51.68 52.8 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.47 ' O ' ' HG2' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -121.67 -36.45 3.04 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.281 -1.129 . . . . 0.0 108.834 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 69.4 mt -83.11 -44.47 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.457 -0.777 . . . . 0.0 109.526 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -46.71 -34.5 5.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.873 . . . . 0.0 109.214 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 11' ' ' PHE . 13.2 pt-20 -86.12 -39.87 16.27 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.3 -0.875 . . . . 0.0 108.728 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.523 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 7.2 t-20 -54.29 -17.72 3.24 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.975 -1.078 . . . . 0.0 108.202 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.404 ' N ' ' C ' ' A' ' 7' ' ' GLU . 6.8 mm -98.23 -15.5 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.47 -0.769 . . . . 0.0 109.602 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.577 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -121.96 -52.32 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.577 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 1.6 t80 -51.63 -28.1 13.36 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.64 -38.89 13.01 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.1 t -71.64 -32.51 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -1.103 . . . . 0.0 108.832 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 18' ' ' TYR . 8.2 t -66.38 -39.11 88.89 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.265 -0.897 . . . . 0.0 108.899 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.454 ' O ' ' N ' ' A' ' 18' ' ' TYR . 2.4 t80 -62.25 -55.14 31.32 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.289 -0.882 . . . . 0.0 108.817 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 15' ' ' TYR . 93.5 m-20 -46.73 -30.77 2.56 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -90.17 -27.89 19.27 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.456 ' N ' ' O ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -72.44 -37.56 68.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.315 -0.866 . . . . 0.0 109.011 179.6 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.497 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 4.1 mtm180 -77.01 -44.13 32.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.063 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.547 ' CD1' ' C ' ' A' ' 20' ' ' TYR . 6.2 t80 -49.48 -26.25 3.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.363 -0.836 . . . . 0.0 108.984 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 25' ' ' LYS . 1.9 ttp180 -77.61 -51.6 10.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.375 -0.828 . . . . 0.0 109.236 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -67.25 -12.99 61.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.881 . . . . 0.0 109.305 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.497 ' CG2' ' O ' ' A' ' 19' ' ' ARG . 14.3 t -89.0 -24.26 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.218 -0.926 . . . . 0.0 109.612 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.507 ' CG2' ' O ' ' A' ' 24' ' ' ILE . 2.2 mp -121.37 -0.67 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.954 . . . . 0.0 109.526 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -133.98 72.01 1.47 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.185 -0.947 . . . . 0.0 109.425 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.56 -179.85 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.821 0.343 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.29 178.95 5.47 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.912 1.48 . . . . 0.0 110.525 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 79.71 52.56 4.66 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.472 HG21 ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -137.88 -42.79 0.53 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -1.13 . . . . 0.0 109.167 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.472 ' N ' HG21 ' A' ' 4' ' ' THR . 42.1 mm -47.75 -37.12 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.443 -0.786 . . . . 0.0 109.147 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -77.25 -52.31 9.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.378 -0.826 . . . . 0.0 109.142 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 11' ' ' PHE . 1.1 mm-40 -59.29 -42.88 92.31 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.271 -0.893 . . . . 0.0 109.043 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -46.6 -23.82 0.45 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.068 -1.02 . . . . 0.0 109.275 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 5' ' ' ILE . 4.1 mm -97.57 -15.74 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.827 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.4 OUTLIER -120.55 -52.11 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.106 -0.996 . . . . 0.0 108.589 179.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.573 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -42.17 -32.36 0.47 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.6 -45.3 13.76 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.87 -32.02 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.436 -1.038 . . . . 0.0 108.824 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.5 -32.56 54.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.405 -0.809 . . . . 0.0 109.018 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -62.48 -53.31 56.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -0.846 . . . . 0.0 108.861 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.0 -22.87 2.52 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -99.39 -17.17 18.13 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.466 -0.771 . . . . 0.0 109.267 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.93 -54.07 4.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 0.0 109.829 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.482 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -56.73 -25.26 54.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 110.02 -179.553 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.432 ' O ' HD11 ' A' ' 24' ' ' ILE . 88.5 t80 -68.95 -45.0 71.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.188 -0.945 . . . . 0.0 109.957 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.17 -33.47 67.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.92 . . . . 0.0 109.834 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.7 t -74.67 -4.49 37.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 0.0 110.163 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' A' ' 19' ' ' ARG . 61.3 t -107.83 -31.95 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.04 -1.037 . . . . 0.0 110.078 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.516 ' N ' HD11 ' A' ' 24' ' ' ILE . 2.4 mp -106.91 -17.0 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.052 -1.03 . . . . 0.0 109.777 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.64 94.04 2.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -0.956 . . . . 0.0 109.64 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.414 179.934 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.72 178.75 6.38 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.85 1.448 . . . . 0.0 110.183 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 52.77 45.31 60.83 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.556 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -82.26 -49.87 9.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -1.182 . . . . 0.0 109.395 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.556 ' N ' ' CG2' ' A' ' 4' ' ' THR . 22.2 mm -53.89 -40.02 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.431 -0.793 . . . . 0.0 109.655 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -61.82 -51.51 67.96 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.367 -0.833 . . . . 0.0 109.424 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.58 ' HG3' ' N ' ' A' ' 8' ' ' ASN . 0.8 OUTLIER -64.2 -29.74 70.83 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.192 -0.943 . . . . 0.0 109.175 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.58 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 1.8 t30 -63.57 -11.29 23.4 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.718 -1.238 . . . . 0.0 108.229 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.501 HD11 HG22 ' A' ' 9' ' ' ILE . 39.6 mt -109.02 -8.65 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.462 -0.774 . . . . 0.0 109.861 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.4 OUTLIER -124.37 -42.99 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.555 ' N ' ' O ' ' A' ' 7' ' ' GLU . 13.8 t80 -45.11 -32.55 1.81 Allowed 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.029 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.82 -49.96 4.86 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.63 -35.23 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -1.179 . . . . 0.0 108.941 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -65.05 -45.47 85.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.359 -0.838 . . . . 0.0 109.113 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.474 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -57.64 -53.12 61.74 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.394 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 15' ' ' TYR . 1.5 m-20 -45.69 -30.8 1.68 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.01 -26.9 18.15 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.474 ' N ' ' O ' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -69.83 -44.7 69.42 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.454 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -69.06 -28.52 66.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 0.0 109.286 179.782 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.405 ' O ' HD11 ' A' ' 24' ' ' ILE . 33.9 t80 -75.13 -12.02 60.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.3 -0.875 . . . . 0.0 109.324 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -100.85 -45.03 5.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.845 . . . . 0.0 109.432 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 48.0 t -71.77 -37.62 70.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 0.0 109.47 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 19' ' ' ARG . 73.1 t -63.02 -49.37 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.329 -0.857 . . . . 0.0 109.459 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.577 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 2.7 mp -91.77 8.88 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.632 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 22' ' ' SER . 0.6 OUTLIER -49.91 147.42 3.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.572 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.069 -0.967 . . . . 0.0 109.469 -179.94 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 ttm . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 120.754 0.311 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.46 173.45 13.17 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.079 1.568 . . . . 0.0 110.561 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.44 67.34 1.77 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.446 HG21 ' N ' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -116.54 -38.31 3.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.297 -1.12 . . . . 0.0 109.238 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.469 ' O ' HG13 ' A' ' 9' ' ' ILE . 34.2 mm -55.7 -46.89 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.312 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' HG3' ' N ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -60.99 -36.51 79.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.361 -0.837 . . . . 0.0 109.207 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 11' ' ' PHE . 2.1 mm-40 -70.17 -50.46 40.07 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.893 . . . . 0.0 108.963 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -48.16 -23.11 0.76 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 109.47 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 5' ' ' ILE . 18.2 mt -91.97 -13.36 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.302 -0.874 . . . . 0.0 109.866 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.55 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -119.07 -49.59 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.55 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -43.86 -36.28 2.3 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.57 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.99 -54.97 8.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.95 -47.34 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -61.6 -24.65 66.83 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.488 ' O ' ' N ' ' A' ' 18' ' ' TYR . 11.6 t80 -61.17 -57.72 11.29 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 15' ' ' TYR . 44.7 m-20 -45.36 -28.67 0.89 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -94.73 -26.18 16.38 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.526 ' N ' ' O ' ' A' ' 14' ' ' SER . 9.9 t80 -76.38 -41.22 48.73 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -45.6 -37.8 5.93 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.235 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 20' ' ' TYR . 1.5 t80 -68.49 -42.97 77.88 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 4.5 mtt85 -67.99 -27.44 66.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.452 -0.78 . . . . 0.0 109.362 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.4 t -79.87 -44.54 20.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.404 -0.81 . . . . 0.0 109.865 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.406 ' HB ' HD13 ' A' ' 24' ' ' ILE . 42.1 t -57.87 -46.09 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.145 -0.972 . . . . 0.0 109.606 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.47 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 3.2 mp -93.52 -13.22 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.906 . . . . 0.0 109.517 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.479 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 0.6 OUTLIER 42.38 84.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.745 179.734 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 25' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.524 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.566 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 121.53 0.681 . . . . 0.0 109.181 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.566 ' N ' ' CG2' ' A' ' 4' ' ' THR . 26.7 mm -67.27 -47.19 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.541 -0.725 . . . . 0.0 109.879 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 5' ' ' ILE . 30.1 tptt -45.19 -34.95 3.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.931 . . . . 0.0 109.058 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 11' ' ' PHE . 1.7 mt-10 -67.02 -47.46 71.35 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.398 -0.814 . . . . 0.0 108.815 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -55.51 -17.46 5.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.254 -0.904 . . . . 0.0 109.224 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.492 HG12 ' O ' ' A' ' 5' ' ' ILE . 6.5 mm -89.51 -14.34 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 109.226 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.496 HD13 ' HB ' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -114.66 -38.82 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.491 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.7 OUTLIER -52.61 -33.54 46.82 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.23 179.417 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.08 -41.11 40.82 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.496 ' HB ' HD13 ' A' ' 10' ' ' ILE . 76.2 t -59.07 -18.56 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.526 -0.985 . . . . 0.0 108.689 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 t -98.25 -52.19 3.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.486 -0.759 . . . . 0.0 109.227 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.575 ' CE2' ' HD2' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -60.42 -52.35 65.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.283 -0.885 . . . . 0.0 109.034 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 3.5 m-20 -49.46 -25.13 2.39 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -87.74 -22.82 24.37 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 15' ' ' TYR . 7.4 m-85 -89.08 -27.83 20.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 109.498 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.575 ' HD2' ' CE2' ' A' ' 15' ' ' TYR . 32.8 mtp180 -95.74 -4.32 44.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.257 -0.902 . . . . 0.0 109.556 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 44.5 t80 -89.96 -40.46 12.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.55 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.69 -26.52 62.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.153 -0.967 . . . . 0.0 109.627 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.5 t -70.33 -58.89 3.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.393 -0.817 . . . . 0.0 109.926 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 90.2 t . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.233 -0.917 . . . . 0.0 110.113 -179.517 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.491 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.491 ' N ' ' CG2' ' A' ' 4' ' ' THR . 24.5 mt -49.89 -34.25 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.42 -0.8 . . . . 0.0 109.644 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -83.19 -24.44 32.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.629 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 11' ' ' PHE . 1.5 mm-40 -86.47 -47.16 9.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.934 . . . . 0.0 109.546 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -58.01 -14.1 5.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.224 -0.922 . . . . 0.0 109.669 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 9' ' ' ILE . 33.1 mt -103.48 -7.17 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.855 . . . . 0.0 109.683 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.519 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -120.84 -45.81 2.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.519 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -45.85 -36.32 5.18 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.723 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.32 -49.07 9.76 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 41.2 t -60.88 -40.09 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.424 -1.045 . . . . 0.0 109.015 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -57.84 -52.03 67.17 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.302 -0.874 . . . . 0.0 108.865 179.713 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.17 -55.21 27.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.417 -0.802 . . . . 0.0 108.85 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 20' ' ' TYR . 0.8 OUTLIER -51.35 -23.4 3.66 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.09 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 5.3 tt0 -97.95 -22.24 16.42 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.636 -0.665 . . . . 0.0 109.26 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -76.16 -30.72 58.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.098 -1.001 . . . . 0.0 109.455 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -106.26 10.7 31.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.335 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.415 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 72.8 t80 -119.57 -40.77 2.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.449 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.2 -42.33 55.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 109.5 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.5 t -52.44 -34.0 46.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.368 -0.832 . . . . 0.0 109.709 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 109.578 -179.908 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.41 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.49 ' O ' HG12 ' A' ' 9' ' ' ILE . 3.6 mt -88.35 -53.63 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.347 -0.846 . . . . 0.0 109.204 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 tmmt? -46.01 -25.57 0.58 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 109.482 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 11' ' ' PHE . 1.6 mm-40 -97.25 -47.99 5.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.902 . . . . 0.0 109.314 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -54.52 -17.91 3.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.371 -0.831 . . . . 0.0 109.434 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 5' ' ' ILE . 4.1 mm -103.73 -7.51 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -0.854 . . . . 0.0 109.652 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.554 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -122.72 -49.72 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.554 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.9 OUTLIER -48.48 -32.91 8.51 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.021 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.14 -46.86 8.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.8 t -57.28 -26.84 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -1.151 . . . . 0.0 109.156 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.5 t -79.02 -54.22 6.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.295 -0.878 . . . . 0.0 109.389 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.503 ' O ' ' N ' ' A' ' 18' ' ' TYR . 1.6 t80 -59.24 -55.04 39.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 108.782 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 15' ' ' TYR . 10.0 t0 -46.41 -26.66 0.88 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.35 -22.96 18.01 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.48 -0.763 . . . . 0.0 109.146 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 15' ' ' TYR . 0.6 OUTLIER -81.82 -25.83 34.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 109.543 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.23 -7.27 24.86 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.182 -0.949 . . . . 0.0 109.505 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.448 ' O ' HG12 ' A' ' 23' ' ' VAL . 58.8 t80 -106.4 -29.34 9.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.694 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -90.54 -44.93 9.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.045 -1.034 . . . . 0.0 109.537 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.5 t -49.5 -21.4 0.94 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.383 -0.823 . . . . 0.0 109.864 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 20' ' ' TYR . 11.5 p . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.107 -0.995 . . . . 0.0 109.77 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.418 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.418 ' N ' ' CG2' ' A' ' 4' ' ' THR . 3.5 mt -58.23 -50.7 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.595 -0.69 . . . . 0.0 109.616 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -51.61 -24.71 5.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 109.533 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 11' ' ' PHE . 0.9 OUTLIER -92.05 -47.92 7.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 109.685 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -63.22 -11.88 24.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.197 -0.939 . . . . 0.0 109.346 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.468 HG22 ' O ' ' A' ' 9' ' ' ILE . 14.2 mt -100.88 -12.42 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 109.512 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.596 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -108.87 -50.75 7.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.596 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -47.08 -38.94 12.12 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.848 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.478 ' N ' ' CD1' ' A' ' 11' ' ' PHE . . . -70.28 -38.07 71.26 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 9' ' ' ILE . 91.0 t -63.71 -45.67 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.232 -1.158 . . . . 0.0 109.041 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.9 t -54.61 -35.38 63.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.907 . . . . 0.0 109.125 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.489 ' O ' ' N ' ' A' ' 18' ' ' TYR . 2.4 t80 -71.83 -62.06 1.56 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.385 -0.822 . . . . 0.0 109.206 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 15' ' ' TYR . 74.6 m-20 -46.0 -26.61 0.75 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.213 -0.93 . . . . 0.0 108.623 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.82 -22.34 18.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.436 -0.79 . . . . 0.0 109.206 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.489 ' N ' ' O ' ' A' ' 15' ' ' TYR . 47.1 t80 -83.75 -52.3 6.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.953 . . . . 0.0 109.446 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.57 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -60.88 -37.07 80.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.106 -0.996 . . . . 0.0 109.22 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -59.34 -33.66 71.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.308 -0.87 . . . . 0.0 109.308 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.41 -28.3 66.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.621 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.6 t -83.57 -17.15 42.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 109.44 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 19' ' ' ARG . 61.4 t . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 109.283 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 5' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.493 ' O ' HG12 ' A' ' 9' ' ' ILE . 31.0 mm -68.8 -45.39 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.331 -0.856 . . . . 0.0 109.516 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -46.06 -34.38 4.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.143 -0.973 . . . . 0.0 108.797 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 11' ' ' PHE . 7.7 mm-40 -68.88 -59.08 3.31 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.376 -0.827 . . . . 0.0 109.116 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -54.89 -19.24 6.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 0.0 109.422 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 5' ' ' ILE . 4.2 mm -93.67 -10.88 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 109.452 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.455 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -113.83 -39.04 2.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 179.561 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -58.08 -30.42 66.22 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.834 179.381 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.69 -45.02 29.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.446 -1.862 . . . . 0.0 108.446 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.7 t -54.15 -23.59 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.419 -1.048 . . . . 0.0 108.289 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 t -94.47 -45.61 7.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.569 ' CD2' ' HD2' ' A' ' 19' ' ' ARG . 1.9 t80 -65.33 -57.75 7.61 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -49.3 -24.73 1.97 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -91.04 -24.63 20.0 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.481 ' N ' ' O ' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -80.34 -43.96 20.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.333 -0.854 . . . . 0.0 109.448 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.569 ' HD2' ' CD2' ' A' ' 15' ' ' TYR . 4.1 mtt180 -67.65 -20.31 65.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 109.639 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -76.26 -31.09 58.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.144 -0.973 . . . . 0.0 109.717 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.16 -40.75 15.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.289 -0.882 . . . . 0.0 109.672 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -69.11 -32.92 72.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 109.851 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.152 -0.968 . . . . 0.0 109.747 -179.799 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.542 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.542 ' N ' ' CG2' ' A' ' 4' ' ' THR . 87.0 mt -83.07 -47.16 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.504 -0.747 . . . . 0.0 109.438 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -48.19 -37.53 15.99 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.183 -0.948 . . . . 0.0 109.046 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.536 ' HG3' ' N ' ' A' ' 8' ' ' ASN . 14.9 pt-20 -82.7 -37.36 24.87 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.352 -0.843 . . . . 0.0 109.069 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.536 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 26.4 t30 -68.6 -6.86 28.08 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.311 -0.868 . . . . 0.0 108.728 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 5' ' ' ILE . 27.9 mt -104.65 -12.16 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.424 -0.798 . . . . 0.0 109.421 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.486 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.4 OUTLIER -107.49 -46.3 7.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.486 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -43.38 -31.32 0.65 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.48 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.15 -35.82 22.88 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 10' ' ' ILE . 60.0 t -79.6 -23.03 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.419 -1.048 . . . . 0.0 109.131 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.557 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 1.1 t -85.98 -41.46 14.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.252 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 18' ' ' TYR . 2.2 t80 -61.2 -56.78 16.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.24 -0.912 . . . . 0.0 108.585 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -49.5 -24.8 2.23 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.43 -23.47 18.39 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.557 ' CD1' ' O ' ' A' ' 14' ' ' SER . 8.3 m-30 -76.32 -59.24 2.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 0.0 109.641 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -18.88 52.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.934 . . . . 0.0 109.444 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.808 ' O ' HG12 ' A' ' 23' ' ' VAL . 43.8 t80 -78.47 -60.34 2.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 109.217 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.3 tmm_? -48.91 -38.11 21.78 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.1 t -56.7 -41.36 77.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.457 -0.777 . . . . 0.0 109.744 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.808 HG12 ' O ' ' A' ' 20' ' ' TYR . 2.9 p . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.113 -0.992 . . . . 0.0 109.439 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.507 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.507 ' N ' ' CG2' ' A' ' 4' ' ' THR . 2.3 mp -57.45 -51.86 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.524 -0.735 . . . . 0.0 109.213 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -47.42 -36.27 9.61 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.553 ' O ' ' N ' ' A' ' 11' ' ' PHE . 3.1 mt-10 -69.57 -45.73 68.0 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -49.47 -21.36 0.91 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.124 -0.985 . . . . 0.0 108.92 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.1 mt -93.83 -13.78 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.204 -0.935 . . . . 0.0 109.86 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.531 HG22 ' N ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -124.85 -52.23 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.553 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.9 OUTLIER -47.31 -28.96 2.21 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.719 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.25 -34.58 29.09 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' A' ' 10' ' ' ILE . 53.8 t -79.45 -26.13 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.488 -1.007 . . . . 0.0 109.027 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.4 OUTLIER -79.13 -30.69 43.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.446 -0.784 . . . . 0.0 109.161 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.449 ' HA ' ' HB3' ' A' ' 18' ' ' TYR . 2.4 t80 -69.76 -53.3 18.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.253 -0.905 . . . . 0.0 108.828 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.24 -26.47 11.87 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.14 -17.27 17.49 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 14' ' ' SER . 12.5 t80 -87.36 -55.73 3.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.379 -0.826 . . . . 0.0 109.391 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.454 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -46.55 -25.75 0.75 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.253 -0.904 . . . . 0.0 109.05 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -85.54 -34.01 21.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.316 -0.865 . . . . 0.0 109.068 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' A' ' 18' ' ' TYR . 1.7 ttp180 -81.18 -22.93 38.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.943 . . . . 0.0 109.447 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.6 t -69.55 -25.13 63.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.323 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 19' ' ' ARG . 3.8 t . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.364 -0.835 . . . . 0.0 109.406 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.34 -49.62 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.382 -0.824 . . . . 0.0 109.341 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -57.03 -37.0 71.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -0.876 . . . . 0.0 109.272 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 11' ' ' PHE . 5.1 mm-40 -61.66 -50.93 70.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.875 . . . . 0.0 109.145 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -51.15 -20.36 1.48 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.906 -1.121 . . . . 0.0 109.014 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 9' ' ' ILE . 33.6 mt -108.1 -7.66 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 110.385 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -126.71 -41.25 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.084 -1.01 . . . . 0.0 108.51 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.559 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -47.72 -31.61 4.92 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.541 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.34 -44.31 6.63 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 92.0 t -72.12 -21.0 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.431 -1.04 . . . . 0.0 108.929 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.57 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -82.5 -49.17 10.2 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.489 ' CZ ' ' HG3' ' A' ' 19' ' ' ARG . 4.7 t80 -52.94 -50.51 63.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 108.772 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -53.63 -19.72 4.33 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.44 ' O ' ' NH1' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -117.97 -0.12 11.75 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.329 -0.857 . . . . 0.0 109.536 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.57 ' N ' ' O ' ' A' ' 14' ' ' SER . 7.2 t80 -104.99 -59.19 1.78 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.105 -0.997 . . . . 0.0 109.948 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.561 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -49.75 -30.52 9.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.146 -0.971 . . . . 0.0 109.509 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -75.16 -48.75 22.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.492 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.44 ' NH1' ' O ' ' A' ' 17' ' ' GLU . 19.9 mtm-85 -71.03 -34.92 71.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.368 -0.833 . . . . 0.0 109.525 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.2 t -59.09 -15.35 13.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.192 -0.942 . . . . 0.0 109.467 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 19' ' ' ARG . 48.9 t . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.473 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.443 0.639 . . . . 0.0 109.316 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.518 ' O ' HG12 ' A' ' 9' ' ' ILE . 4.0 mt -56.17 -52.6 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.318 -0.864 . . . . 0.0 109.622 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.501 ' HG3' ' HG2' ' A' ' 7' ' ' GLU . 12.8 pttm -43.76 -28.87 0.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.417 -0.802 . . . . 0.0 109.525 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.501 ' HG2' ' HG3' ' A' ' 6' ' ' LYS . 3.9 mm-40 -85.58 -49.43 8.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.44 -0.787 . . . . 0.0 109.704 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -59.64 -14.29 13.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 0.0 109.657 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 5' ' ' ILE . 14.6 mm -91.71 -15.27 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 109.283 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.602 HG22 ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -115.21 -55.82 4.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.602 ' N ' HG22 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -46.8 -28.17 1.46 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.385 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 16' ' ' ASP . . . -75.57 -45.21 18.68 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 58.1 t -54.37 -20.27 4.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.561 -0.964 . . . . 0.0 108.548 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.451 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 0.4 OUTLIER -103.17 -51.23 3.29 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.71 -0.619 . . . . 0.0 109.482 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.454 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.3 OUTLIER -72.02 -60.31 2.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -0.928 . . . . 0.0 109.439 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.54 ' O ' ' CB ' ' A' ' 20' ' ' TYR . 4.2 m-20 -50.39 -21.83 1.6 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.047 -1.033 . . . . 0.0 108.485 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -96.29 -17.37 20.77 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.383 -0.823 . . . . 0.0 109.266 179.413 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.454 ' N ' ' O ' ' A' ' 15' ' ' TYR . 1.1 m-85 -99.05 -41.75 7.41 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.192 -0.943 . . . . 0.0 110.68 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.2 -4.35 54.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.009 -1.057 . . . . 0.0 110.426 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.54 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 22.7 t80 -95.42 -72.72 0.61 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.997 -1.064 . . . . 0.0 109.656 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.02 -31.3 2.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.278 -0.889 . . . . 0.0 109.325 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.4 t -61.83 -14.81 36.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.37 -0.832 . . . . 0.0 109.883 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.154 -0.966 . . . . 0.0 109.732 -179.86 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.493 ' O ' ' HG2' ' A' ' 7' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.416 HG13 HG22 ' A' ' 4' ' ' THR . 69.4 mt -83.11 -44.47 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.457 -0.777 . . . . 0.0 109.526 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -46.71 -34.5 5.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.873 . . . . 0.0 109.214 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 11' ' ' PHE . 13.2 pt-20 -86.12 -39.87 16.27 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.3 -0.875 . . . . 0.0 108.728 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.54 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 7.2 t-20 -54.29 -17.72 3.24 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.975 -1.078 . . . . 0.0 108.202 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.404 ' N ' ' C ' ' A' ' 7' ' ' GLU . 6.8 mm -98.23 -15.5 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.47 -0.769 . . . . 0.0 109.602 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.577 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -121.96 -52.32 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.577 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 1.6 t80 -51.63 -28.1 13.36 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.64 -38.89 13.01 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.1 t -71.64 -32.51 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -1.103 . . . . 0.0 108.832 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 18' ' ' TYR . 8.2 t -66.38 -39.11 88.89 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.265 -0.897 . . . . 0.0 108.899 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.454 ' O ' ' N ' ' A' ' 18' ' ' TYR . 2.4 t80 -62.25 -55.14 31.32 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.289 -0.882 . . . . 0.0 108.817 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 15' ' ' TYR . 93.5 m-20 -46.73 -30.77 2.56 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -90.17 -27.89 19.27 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.456 ' N ' ' O ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -72.44 -37.56 68.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.315 -0.866 . . . . 0.0 109.011 179.6 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 1.032 ' O ' HG23 ' A' ' 23' ' ' VAL . 4.1 mtm180 -77.01 -44.13 32.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.063 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.547 ' CD1' ' C ' ' A' ' 20' ' ' TYR . 6.2 t80 -49.48 -26.25 3.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.363 -0.836 . . . . 0.0 108.984 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -77.61 -51.6 10.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.375 -0.828 . . . . 0.0 109.236 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -67.25 -12.99 61.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.881 . . . . 0.0 109.305 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.032 HG23 ' O ' ' A' ' 19' ' ' ARG . 14.3 t . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.218 -0.926 . . . . 0.0 109.612 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.407 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.478 ' O ' HG12 ' A' ' 9' ' ' ILE . 42.1 mm -47.75 -37.12 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.443 -0.786 . . . . 0.0 109.147 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -77.25 -52.31 9.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.378 -0.826 . . . . 0.0 109.142 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 11' ' ' PHE . 1.1 mm-40 -59.29 -42.88 92.31 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.271 -0.893 . . . . 0.0 109.043 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -46.6 -23.82 0.45 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.068 -1.02 . . . . 0.0 109.275 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 5' ' ' ILE . 4.1 mm -97.57 -15.74 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.827 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.4 OUTLIER -120.55 -52.11 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.106 -0.996 . . . . 0.0 108.589 179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.573 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -42.17 -32.36 0.47 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.93 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.6 -45.3 13.76 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.87 -32.02 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.436 -1.038 . . . . 0.0 108.824 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.5 -32.56 54.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.405 -0.809 . . . . 0.0 109.018 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.468 ' HB2' ' O ' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -62.48 -53.31 56.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -0.846 . . . . 0.0 108.861 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.0 -22.87 2.52 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -99.39 -17.17 18.13 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.466 -0.771 . . . . 0.0 109.267 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.93 -54.07 4.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 0.0 109.829 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.876 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -56.73 -25.26 54.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 110.02 -179.553 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -68.95 -45.0 71.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.188 -0.945 . . . . 0.0 109.957 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.17 -33.47 67.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.92 . . . . 0.0 109.834 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.7 t -74.67 -4.49 37.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 0.0 110.163 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 19' ' ' ARG . 61.3 t . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.04 -1.037 . . . . 0.0 110.078 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.556 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.412 0.625 . . . . 0.0 109.395 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.556 ' N ' ' CG2' ' A' ' 4' ' ' THR . 22.2 mm -53.89 -40.02 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.431 -0.793 . . . . 0.0 109.655 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -61.82 -51.51 67.96 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.367 -0.833 . . . . 0.0 109.424 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.589 ' HG3' ' N ' ' A' ' 8' ' ' ASN . 0.8 OUTLIER -64.2 -29.74 70.83 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.192 -0.943 . . . . 0.0 109.175 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.589 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 14.5 t-20 -63.57 -11.29 23.4 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.718 -1.238 . . . . 0.0 108.229 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 9' ' ' ILE . 39.6 mt -109.02 -8.65 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.462 -0.774 . . . . 0.0 109.861 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.511 HG22 ' HA ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -124.37 -42.99 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.555 ' N ' ' O ' ' A' ' 7' ' ' GLU . 13.8 t80 -45.11 -32.55 1.81 Allowed 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.029 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.82 -49.96 4.86 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.63 -35.23 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -1.179 . . . . 0.0 108.941 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -65.05 -45.47 85.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.359 -0.838 . . . . 0.0 109.113 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.474 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -57.64 -53.12 61.74 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.394 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 15' ' ' TYR . 1.5 m-20 -45.69 -30.8 1.68 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.01 -26.9 18.15 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.474 ' N ' ' O ' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -69.83 -44.7 69.42 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.56 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -69.06 -28.52 66.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 0.0 109.286 179.782 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -75.13 -12.02 60.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.3 -0.875 . . . . 0.0 109.324 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -100.85 -45.03 5.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.845 . . . . 0.0 109.432 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.0 t -71.77 -37.62 70.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 0.0 109.47 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 19' ' ' ARG . 73.1 t . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.329 -0.857 . . . . 0.0 109.459 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.472 ' O ' HG13 ' A' ' 9' ' ' ILE . 34.2 mm -55.7 -46.89 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.312 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.436 ' HG3' ' N ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -60.99 -36.51 79.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.361 -0.837 . . . . 0.0 109.207 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 11' ' ' PHE . 2.1 mm-40 -70.17 -50.46 40.07 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.893 . . . . 0.0 108.963 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -48.16 -23.11 0.76 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 109.47 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 5' ' ' ILE . 18.2 mt -91.97 -13.36 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.302 -0.874 . . . . 0.0 109.866 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.55 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -119.07 -49.59 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.55 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -43.86 -36.28 2.3 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.57 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.99 -54.97 8.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.95 -47.34 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -61.6 -24.65 66.83 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.783 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.488 ' O ' ' N ' ' A' ' 18' ' ' TYR . 11.6 t80 -61.17 -57.72 11.29 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 15' ' ' TYR . 44.7 m-20 -45.36 -28.67 0.89 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -94.73 -26.18 16.38 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.526 ' N ' ' O ' ' A' ' 14' ' ' SER . 9.9 t80 -76.38 -41.22 48.73 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.876 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -45.6 -37.8 5.93 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.235 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 20' ' ' TYR . 1.5 t80 -68.49 -42.97 77.88 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -67.99 -27.44 66.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.452 -0.78 . . . . 0.0 109.362 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.4 t -79.87 -44.54 20.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.404 -0.81 . . . . 0.0 109.865 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 19' ' ' ARG . 42.1 t . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.145 -0.972 . . . . 0.0 109.606 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.5 72.36 3.65 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.881 1.463 . . . . 0.0 110.449 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -127.87 25.92 4.89 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.566 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -56.83 -49.51 75.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.353 -1.086 . . . . 0.0 109.181 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.566 ' N ' ' CG2' ' A' ' 4' ' ' THR . 26.7 mm -67.27 -47.19 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.541 -0.725 . . . . 0.0 109.879 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 5' ' ' ILE . 30.1 tptt -45.19 -34.95 3.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.931 . . . . 0.0 109.058 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 11' ' ' PHE . 1.7 mt-10 -67.02 -47.46 71.35 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.398 -0.814 . . . . 0.0 108.815 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -55.51 -17.46 5.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.254 -0.904 . . . . 0.0 109.224 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.492 HG12 ' O ' ' A' ' 5' ' ' ILE . 6.5 mm -89.51 -14.34 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 109.226 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.496 HD13 ' HB ' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -114.66 -38.82 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.491 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.7 OUTLIER -52.61 -33.54 46.82 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.23 179.417 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.08 -41.11 40.82 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.496 ' HB ' HD13 ' A' ' 10' ' ' ILE . 76.2 t -59.07 -18.56 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.526 -0.985 . . . . 0.0 108.689 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 t -98.25 -52.19 3.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.486 -0.759 . . . . 0.0 109.227 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.575 ' CE2' ' HD2' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -60.42 -52.35 65.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.283 -0.885 . . . . 0.0 109.034 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 3.5 m-20 -49.46 -25.13 2.39 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -87.74 -22.82 24.37 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 15' ' ' TYR . 7.4 m-85 -89.08 -27.83 20.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 109.498 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.575 ' HD2' ' CE2' ' A' ' 15' ' ' TYR . 32.8 mtp180 -95.74 -4.32 44.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.257 -0.902 . . . . 0.0 109.556 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 44.5 t80 -89.96 -40.46 12.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.55 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.69 -26.52 62.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.153 -0.967 . . . . 0.0 109.627 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.5 t -70.33 -58.89 3.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.393 -0.817 . . . . 0.0 109.926 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.556 ' C ' HD12 ' A' ' 24' ' ' ILE . 90.2 t -58.49 -35.23 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.233 -0.917 . . . . 0.0 110.113 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.774 HG22 ' O ' ' A' ' 24' ' ' ILE . 1.7 mp -98.41 16.69 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.138 -0.976 . . . . 0.0 109.378 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -64.95 107.48 1.5 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.053 -1.029 . . . . 0.0 109.638 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 25' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.585 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.778 0.323 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -75.57 70.36 5.7 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.103 1.581 . . . . 0.0 110.424 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -127.68 14.9 6.35 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.491 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -62.66 -46.54 87.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -1.145 . . . . 0.0 109.299 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.491 ' N ' ' CG2' ' A' ' 4' ' ' THR . 24.5 mt -49.89 -34.25 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.42 -0.8 . . . . 0.0 109.644 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -83.19 -24.44 32.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.629 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 11' ' ' PHE . 1.5 mm-40 -86.47 -47.16 9.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.934 . . . . 0.0 109.546 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -58.01 -14.1 5.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.224 -0.922 . . . . 0.0 109.669 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 9' ' ' ILE . 33.1 mt -103.48 -7.17 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.855 . . . . 0.0 109.683 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.519 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -120.84 -45.81 2.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.519 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -45.85 -36.32 5.18 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.723 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.32 -49.07 9.76 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 41.2 t -60.88 -40.09 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.424 -1.045 . . . . 0.0 109.015 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -57.84 -52.03 67.17 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.302 -0.874 . . . . 0.0 108.865 179.713 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.17 -55.21 27.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.417 -0.802 . . . . 0.0 108.85 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 20' ' ' TYR . 0.8 OUTLIER -51.35 -23.4 3.66 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.09 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 5.3 tt0 -97.95 -22.24 16.42 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.636 -0.665 . . . . 0.0 109.26 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -76.16 -30.72 58.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.098 -1.001 . . . . 0.0 109.455 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -106.26 10.7 31.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.335 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.481 ' CE2' HG21 ' A' ' 24' ' ' ILE . 72.8 t80 -119.57 -40.77 2.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.449 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.515 ' O ' ' N ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -75.2 -42.33 55.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 109.5 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.5 t -52.44 -34.0 46.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.368 -0.832 . . . . 0.0 109.709 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.539 HG13 ' N ' ' A' ' 24' ' ' ILE . 8.7 p -92.98 -41.08 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 109.578 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.586 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.5 tp -88.56 11.22 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.346 -0.846 . . . . 0.0 109.985 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.624 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -64.21 -170.14 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.007 -1.058 . . . . 0.0 109.136 179.717 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 25' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.643 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.723 0.297 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.25 165.1 33.52 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.057 1.556 . . . . 0.0 110.552 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 117.0 27.4 2.72 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.41 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -116.63 -44.73 2.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.363 -1.081 . . . . 0.0 108.913 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.49 ' O ' HG12 ' A' ' 9' ' ' ILE . 3.6 mt -88.35 -53.63 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.347 -0.846 . . . . 0.0 109.204 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 tmmt? -46.01 -25.57 0.58 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 109.482 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 11' ' ' PHE . 1.6 mm-40 -97.25 -47.99 5.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.902 . . . . 0.0 109.314 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -54.52 -17.91 3.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.371 -0.831 . . . . 0.0 109.434 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 5' ' ' ILE . 4.1 mm -103.73 -7.51 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -0.854 . . . . 0.0 109.652 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.554 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -122.72 -49.72 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.554 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.9 OUTLIER -48.48 -32.91 8.51 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.021 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.14 -46.86 8.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.8 t -57.28 -26.84 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -1.151 . . . . 0.0 109.156 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.5 t -79.02 -54.22 6.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.295 -0.878 . . . . 0.0 109.389 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.503 ' O ' ' N ' ' A' ' 18' ' ' TYR . 1.6 t80 -59.24 -55.04 39.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 108.782 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 15' ' ' TYR . 10.0 t0 -46.41 -26.66 0.88 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.35 -22.96 18.01 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.48 -0.763 . . . . 0.0 109.146 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 15' ' ' TYR . 0.6 OUTLIER -81.82 -25.83 34.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 109.543 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.23 -7.27 24.86 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.182 -0.949 . . . . 0.0 109.505 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.499 ' O ' HG12 ' A' ' 24' ' ' ILE . 58.8 t80 -106.4 -29.34 9.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.694 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -90.54 -44.93 9.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.045 -1.034 . . . . 0.0 109.537 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.5 t -49.5 -21.4 0.94 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.383 -0.823 . . . . 0.0 109.864 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.538 HG13 ' N ' ' A' ' 24' ' ' ILE . 11.5 p -92.63 -42.83 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.107 -0.995 . . . . 0.0 109.77 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.538 ' N ' HG13 ' A' ' 23' ' ' VAL . 22.9 mm -76.66 -26.78 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.222 -0.923 . . . . 0.0 109.77 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 26' ' ' ALA . 22.7 tttt -57.79 -54.98 40.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.152 -0.968 . . . . 0.0 109.425 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 25' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.48 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.816 0.341 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.64 -168.02 0.37 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.988 1.52 . . . . 0.0 110.323 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 99.25 -19.13 55.25 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.418 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -81.92 -42.05 20.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -1.144 . . . . 0.0 109.037 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.418 ' N ' ' CG2' ' A' ' 4' ' ' THR . 3.5 mt -58.23 -50.7 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.595 -0.69 . . . . 0.0 109.616 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -51.61 -24.71 5.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 109.533 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 11' ' ' PHE . 0.9 OUTLIER -92.05 -47.92 7.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 109.685 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -63.22 -11.88 24.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.197 -0.939 . . . . 0.0 109.346 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.468 HG22 ' O ' ' A' ' 9' ' ' ILE . 14.2 mt -100.88 -12.42 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 109.512 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.596 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -108.87 -50.75 7.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.596 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -47.08 -38.94 12.12 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.848 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.478 ' N ' ' CD1' ' A' ' 11' ' ' PHE . . . -70.28 -38.07 71.26 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 9' ' ' ILE . 91.0 t -63.71 -45.67 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.232 -1.158 . . . . 0.0 109.041 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.9 t -54.61 -35.38 63.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.907 . . . . 0.0 109.125 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.489 ' O ' ' N ' ' A' ' 18' ' ' TYR . 2.4 t80 -71.83 -62.06 1.56 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.385 -0.822 . . . . 0.0 109.206 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 15' ' ' TYR . 74.6 m-20 -46.0 -26.61 0.75 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.213 -0.93 . . . . 0.0 108.623 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.82 -22.34 18.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.436 -0.79 . . . . 0.0 109.206 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.489 ' N ' ' O ' ' A' ' 15' ' ' TYR . 47.1 t80 -83.75 -52.3 6.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.953 . . . . 0.0 109.446 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.57 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -60.88 -37.07 80.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.106 -0.996 . . . . 0.0 109.22 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -59.34 -33.66 71.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.308 -0.87 . . . . 0.0 109.308 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.41 -28.3 66.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.621 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.6 t -83.57 -17.15 42.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 109.44 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 19' ' ' ARG . 61.4 t -76.69 -34.44 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 109.283 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.757 ' N ' HD12 ' A' ' 24' ' ' ILE . 2.6 mp -104.95 -24.19 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.362 -0.836 . . . . 0.0 109.153 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.515 ' HG3' ' N ' ' A' ' 26' ' ' ALA . 7.8 tptt 40.81 -94.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.554 -0.716 . . . . 0.0 109.839 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.515 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.105 -0.997 . . . . 0.0 109.427 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 120.864 0.364 . . . . 0.0 110.094 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -78.14 169.07 20.92 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.131 1.595 . . . . 0.0 110.199 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 59.33 15.23 30.17 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -119.22 -48.05 2.44 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -1.121 . . . . 0.0 109.018 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.493 ' O ' HG12 ' A' ' 9' ' ' ILE . 31.0 mm -68.8 -45.39 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.331 -0.856 . . . . 0.0 109.516 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -46.06 -34.38 4.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.143 -0.973 . . . . 0.0 108.797 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 11' ' ' PHE . 7.7 mm-40 -68.88 -59.08 3.31 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.376 -0.827 . . . . 0.0 109.116 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -54.89 -19.24 6.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 0.0 109.422 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 5' ' ' ILE . 4.2 mm -93.67 -10.88 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 109.452 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.455 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -113.83 -39.04 2.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 179.561 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -58.08 -30.42 66.22 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.834 179.381 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.69 -45.02 29.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.446 -1.862 . . . . 0.0 108.446 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.7 t -54.15 -23.59 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.419 -1.048 . . . . 0.0 108.289 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 t -94.47 -45.61 7.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.569 ' CD2' ' HD2' ' A' ' 19' ' ' ARG . 1.9 t80 -65.33 -57.75 7.61 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -49.3 -24.73 1.97 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -91.04 -24.63 20.0 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.481 ' N ' ' O ' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -80.34 -43.96 20.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.333 -0.854 . . . . 0.0 109.448 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.569 ' HD2' ' CD2' ' A' ' 15' ' ' TYR . 4.1 mtt180 -67.65 -20.31 65.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 109.639 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -76.26 -31.09 58.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.144 -0.973 . . . . 0.0 109.717 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.524 ' O ' ' CA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -86.16 -40.75 15.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.289 -0.882 . . . . 0.0 109.672 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -69.11 -32.92 72.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 109.851 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.774 HG13 HD12 ' A' ' 24' ' ' ILE . 7.6 p -74.13 -46.46 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.152 -0.968 . . . . 0.0 109.747 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.804 HG22 ' O ' ' A' ' 24' ' ' ILE . 3.4 mt -123.45 44.32 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 109.173 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.524 ' CA ' ' O ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -45.48 -29.41 1.13 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.253 -0.905 . . . . 0.0 109.578 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.481 -179.946 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.411 ' HA ' ' HD2' ' A' ' 2' ' ' PRO . 4.6 mtt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 120.834 0.35 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 46.1 Cg_endo -72.95 -174.66 1.61 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.059 1.557 . . . . 0.0 110.51 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 88.93 54.28 2.36 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.542 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -108.33 -49.43 3.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.314 -1.109 . . . . 0.0 109.058 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.542 ' N ' ' CG2' ' A' ' 4' ' ' THR . 87.0 mt -83.07 -47.16 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.504 -0.747 . . . . 0.0 109.438 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -48.19 -37.53 15.99 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.183 -0.948 . . . . 0.0 109.046 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.536 ' HG3' ' N ' ' A' ' 8' ' ' ASN . 14.9 pt-20 -82.7 -37.36 24.87 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.352 -0.843 . . . . 0.0 109.069 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.536 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 26.4 t30 -68.6 -6.86 28.08 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.311 -0.868 . . . . 0.0 108.728 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 5' ' ' ILE . 27.9 mt -104.65 -12.16 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.424 -0.798 . . . . 0.0 109.421 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.486 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.4 OUTLIER -107.49 -46.3 7.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.486 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -43.38 -31.32 0.65 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.48 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.15 -35.82 22.88 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 10' ' ' ILE . 60.0 t -79.6 -23.03 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.419 -1.048 . . . . 0.0 109.131 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.557 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 1.1 t -85.98 -41.46 14.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.252 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 18' ' ' TYR . 2.2 t80 -61.2 -56.78 16.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.24 -0.912 . . . . 0.0 108.585 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -49.5 -24.8 2.23 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.43 -23.47 18.39 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.557 ' CD1' ' O ' ' A' ' 14' ' ' SER . 8.3 m-30 -76.32 -59.24 2.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 0.0 109.641 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -18.88 52.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.934 . . . . 0.0 109.444 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.808 ' O ' HG12 ' A' ' 23' ' ' VAL . 43.8 t80 -78.47 -60.34 2.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 109.217 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.3 tmm_? -48.91 -38.11 21.78 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.1 t -56.7 -41.36 77.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.457 -0.777 . . . . 0.0 109.744 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.843 HG13 HD13 ' A' ' 24' ' ' ILE . 2.9 p -72.05 -27.46 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.113 -0.992 . . . . 0.0 109.439 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.843 HD13 HG13 ' A' ' 23' ' ' VAL . 8.9 mm -91.58 2.47 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.386 -0.821 . . . . 0.0 109.536 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.99 -47.7 9.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 109.526 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.387 -179.891 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.873 0.368 . . . . 0.0 110.324 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.5 164.82 34.03 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.006 1.53 . . . . 0.0 110.402 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.8 44.06 21.06 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.507 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -121.92 -47.17 2.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.306 -1.114 . . . . 0.0 109.229 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.507 ' N ' ' CG2' ' A' ' 4' ' ' THR . 2.3 mp -57.45 -51.86 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.524 -0.735 . . . . 0.0 109.213 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -47.42 -36.27 9.61 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.553 ' O ' ' N ' ' A' ' 11' ' ' PHE . 3.1 mt-10 -69.57 -45.73 68.0 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -49.47 -21.36 0.91 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.124 -0.985 . . . . 0.0 108.92 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.1 mt -93.83 -13.78 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.204 -0.935 . . . . 0.0 109.86 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.531 HG22 ' N ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -124.85 -52.23 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.553 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.9 OUTLIER -47.31 -28.96 2.21 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.719 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.25 -34.58 29.09 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' A' ' 10' ' ' ILE . 53.8 t -79.45 -26.13 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.488 -1.007 . . . . 0.0 109.027 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.4 OUTLIER -79.13 -30.69 43.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.446 -0.784 . . . . 0.0 109.161 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.449 ' HA ' ' HB3' ' A' ' 18' ' ' TYR . 2.4 t80 -69.76 -53.3 18.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.253 -0.905 . . . . 0.0 108.828 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.24 -26.47 11.87 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.14 -17.27 17.49 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 14' ' ' SER . 12.5 t80 -87.36 -55.73 3.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.379 -0.826 . . . . 0.0 109.391 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.454 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -46.55 -25.75 0.75 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.253 -0.904 . . . . 0.0 109.05 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -85.54 -34.01 21.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.316 -0.865 . . . . 0.0 109.068 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 25' ' ' LYS . 1.7 ttp180 -81.18 -22.93 38.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.943 . . . . 0.0 109.447 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.6 t -69.55 -25.13 63.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.323 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.673 ' HB ' HD12 ' A' ' 24' ' ' ILE . 3.8 t -88.12 -18.99 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.364 -0.835 . . . . 0.0 109.406 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.768 HG22 ' O ' ' A' ' 24' ' ' ILE . 4.5 mp -142.8 38.61 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.409 -0.807 . . . . 0.0 109.448 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 21' ' ' ARG . 59.4 tttm -54.0 -71.93 0.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.16 -0.963 . . . . 0.0 109.448 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.099 -0.953 . . . . 0.0 109.507 179.935 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mtm . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 120.749 0.309 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.86 63.03 4.89 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.903 1.475 . . . . 0.0 110.597 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -132.97 35.13 2.35 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.57 -37.39 9.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -1.076 . . . . 0.0 109.237 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.34 -49.62 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.382 -0.824 . . . . 0.0 109.341 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -57.03 -37.0 71.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -0.876 . . . . 0.0 109.272 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 11' ' ' PHE . 5.1 mm-40 -61.66 -50.93 70.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.875 . . . . 0.0 109.145 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -51.15 -20.36 1.48 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.906 -1.121 . . . . 0.0 109.014 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 9' ' ' ILE . 33.6 mt -108.1 -7.66 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 110.385 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -126.71 -41.25 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.084 -1.01 . . . . 0.0 108.51 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.559 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -47.72 -31.61 4.92 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.541 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.34 -44.31 6.63 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 92.0 t -72.12 -21.0 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.431 -1.04 . . . . 0.0 108.929 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.57 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -82.5 -49.17 10.2 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.489 ' CZ ' ' HG3' ' A' ' 19' ' ' ARG . 4.7 t80 -52.94 -50.51 63.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 108.772 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -53.63 -19.72 4.33 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.44 ' O ' ' NH1' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -117.97 -0.12 11.75 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.329 -0.857 . . . . 0.0 109.536 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.57 ' N ' ' O ' ' A' ' 14' ' ' SER . 7.2 t80 -104.99 -59.19 1.78 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.105 -0.997 . . . . 0.0 109.948 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.561 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -49.75 -30.52 9.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.146 -0.971 . . . . 0.0 109.509 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -75.16 -48.75 22.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.492 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 25' ' ' LYS . 19.9 mtm-85 -71.03 -34.92 71.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.368 -0.833 . . . . 0.0 109.525 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.2 t -59.09 -15.35 13.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.192 -0.942 . . . . 0.0 109.467 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.601 ' HB ' HD12 ' A' ' 24' ' ' ILE . 48.9 t -98.58 -40.83 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.473 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.601 HD12 ' HB ' ' A' ' 23' ' ' VAL . 3.8 mp -123.74 36.53 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.794 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 21' ' ' ARG . 7.3 tttt -58.61 112.55 1.65 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.167 -0.958 . . . . 0.0 109.41 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 25' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.38 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttm . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 120.892 0.377 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.43 172.64 15.27 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.109 1.584 . . . . 0.0 110.531 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 53.08 32.27 42.35 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.94 -36.41 0.61 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.335 -1.097 . . . . 0.0 109.316 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.518 ' O ' HG12 ' A' ' 9' ' ' ILE . 4.0 mt -56.17 -52.6 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.318 -0.864 . . . . 0.0 109.622 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.501 ' HG3' ' HG2' ' A' ' 7' ' ' GLU . 12.8 pttm -43.76 -28.87 0.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.417 -0.802 . . . . 0.0 109.525 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.501 ' HG2' ' HG3' ' A' ' 6' ' ' LYS . 3.9 mm-40 -85.58 -49.43 8.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.44 -0.787 . . . . 0.0 109.704 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -59.64 -14.29 13.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 0.0 109.657 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 5' ' ' ILE . 14.6 mm -91.71 -15.27 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 109.283 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.602 HG22 ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -115.21 -55.82 4.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.602 ' N ' HG22 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -46.8 -28.17 1.46 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.385 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 16' ' ' ASP . . . -75.57 -45.21 18.68 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 58.1 t -54.37 -20.27 4.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.561 -0.964 . . . . 0.0 108.548 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.451 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 0.4 OUTLIER -103.17 -51.23 3.29 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.71 -0.619 . . . . 0.0 109.482 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.454 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.3 OUTLIER -72.02 -60.31 2.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -0.928 . . . . 0.0 109.439 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.54 ' O ' ' CB ' ' A' ' 20' ' ' TYR . 4.2 m-20 -50.39 -21.83 1.6 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.047 -1.033 . . . . 0.0 108.485 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -96.29 -17.37 20.77 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.383 -0.823 . . . . 0.0 109.266 179.413 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.454 ' N ' ' O ' ' A' ' 15' ' ' TYR . 1.1 m-85 -99.05 -41.75 7.41 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.192 -0.943 . . . . 0.0 110.68 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.2 -4.35 54.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.009 -1.057 . . . . 0.0 110.426 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.54 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 22.7 t80 -95.42 -72.72 0.61 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.997 -1.064 . . . . 0.0 109.656 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -46.02 -31.3 2.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.278 -0.889 . . . . 0.0 109.325 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.4 t -61.83 -14.81 36.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.37 -0.832 . . . . 0.0 109.883 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.546 ' C ' HD12 ' A' ' 24' ' ' ILE . 10.0 t -114.18 -21.81 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.154 -0.966 . . . . 0.0 109.732 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.644 HD12 ' N ' ' A' ' 24' ' ' ILE . 1.5 mp -97.09 -29.51 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 0.0 109.703 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -143.91 139.11 29.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.176 -0.952 . . . . 0.0 109.717 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.388 179.867 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 mtt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.79 153.84 43.15 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.865 1.455 . . . . 0.0 110.391 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 55.39 51.68 52.8 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.493 ' O ' ' HG2' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -121.67 -36.45 3.04 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.281 -1.129 . . . . 0.0 108.834 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.416 HG13 HG22 ' A' ' 4' ' ' THR . 69.4 mt -83.11 -44.47 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.457 -0.777 . . . . 0.0 109.526 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -46.71 -34.5 5.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.873 . . . . 0.0 109.214 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 11' ' ' PHE . 13.2 pt-20 -86.12 -39.87 16.27 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.3 -0.875 . . . . 0.0 108.728 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.54 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 7.2 t-20 -54.29 -17.72 3.24 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.975 -1.078 . . . . 0.0 108.202 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.404 ' N ' ' C ' ' A' ' 7' ' ' GLU . 6.8 mm -98.23 -15.5 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.47 -0.769 . . . . 0.0 109.602 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.577 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -121.96 -52.32 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.577 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 1.6 t80 -51.63 -28.1 13.36 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.64 -38.89 13.01 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.1 t -71.64 -32.51 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -1.103 . . . . 0.0 108.832 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 18' ' ' TYR . 8.2 t -66.38 -39.11 88.89 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.265 -0.897 . . . . 0.0 108.899 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.454 ' O ' ' N ' ' A' ' 18' ' ' TYR . 2.4 t80 -62.25 -55.14 31.32 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.289 -0.882 . . . . 0.0 108.817 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 15' ' ' TYR . 93.5 m-20 -46.73 -30.77 2.56 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -90.17 -27.89 19.27 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.456 ' N ' ' O ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -72.44 -37.56 68.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.315 -0.866 . . . . 0.0 109.011 179.6 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 1.032 ' O ' HG23 ' A' ' 23' ' ' VAL . 4.1 mtm180 -77.01 -44.13 32.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.063 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.547 ' CD1' ' C ' ' A' ' 20' ' ' TYR . 6.2 t80 -49.48 -26.25 3.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.363 -0.836 . . . . 0.0 108.984 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 25' ' ' LYS . 1.9 ttp180 -77.61 -51.6 10.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.375 -0.828 . . . . 0.0 109.236 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -67.25 -12.99 61.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.881 . . . . 0.0 109.305 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.032 HG23 ' O ' ' A' ' 19' ' ' ARG . 14.3 t -89.0 -24.26 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.218 -0.926 . . . . 0.0 109.612 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.754 HD12 ' C ' ' A' ' 23' ' ' VAL . 2.2 mp -121.37 -0.67 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.954 . . . . 0.0 109.526 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -133.98 72.01 1.47 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.185 -0.947 . . . . 0.0 109.425 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.56 -179.85 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HA ' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.821 0.343 . . . . 0.0 110.166 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 45.2 Cg_endo -72.29 178.95 5.47 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.912 1.48 . . . . 0.0 110.525 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 79.71 52.56 4.66 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.407 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -137.88 -42.79 0.53 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -1.13 . . . . 0.0 109.167 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.478 ' O ' HG12 ' A' ' 9' ' ' ILE . 42.1 mm -47.75 -37.12 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.443 -0.786 . . . . 0.0 109.147 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -77.25 -52.31 9.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.378 -0.826 . . . . 0.0 109.142 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 11' ' ' PHE . 1.1 mm-40 -59.29 -42.88 92.31 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.271 -0.893 . . . . 0.0 109.043 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -46.6 -23.82 0.45 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.068 -1.02 . . . . 0.0 109.275 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 5' ' ' ILE . 4.1 mm -97.57 -15.74 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.827 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.4 OUTLIER -120.55 -52.11 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.106 -0.996 . . . . 0.0 108.589 179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.573 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -42.17 -32.36 0.47 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.6 -45.3 13.76 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.87 -32.02 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.436 -1.038 . . . . 0.0 108.824 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.5 -32.56 54.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.405 -0.809 . . . . 0.0 109.018 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.468 ' HB2' ' O ' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -62.48 -53.31 56.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -0.846 . . . . 0.0 108.861 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.0 -22.87 2.52 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -99.39 -17.17 18.13 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.466 -0.771 . . . . 0.0 109.267 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.93 -54.07 4.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 0.0 109.829 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.876 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -56.73 -25.26 54.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 110.02 -179.553 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -68.95 -45.0 71.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.188 -0.945 . . . . 0.0 109.957 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.17 -33.47 67.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.92 . . . . 0.0 109.834 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.7 t -74.67 -4.49 37.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 0.0 110.163 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 19' ' ' ARG . 61.3 t -107.83 -31.95 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.04 -1.037 . . . . 0.0 110.078 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.723 ' N ' HD12 ' A' ' 24' ' ' ILE . 2.4 mp -106.91 -17.0 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.052 -1.03 . . . . 0.0 109.777 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.64 94.04 2.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -0.956 . . . . 0.0 109.64 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.414 179.934 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.72 178.75 6.38 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.85 1.448 . . . . 0.0 110.183 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 52.77 45.31 60.83 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.556 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -82.26 -49.87 9.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -1.182 . . . . 0.0 109.395 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.556 ' N ' ' CG2' ' A' ' 4' ' ' THR . 22.2 mm -53.89 -40.02 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.431 -0.793 . . . . 0.0 109.655 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -61.82 -51.51 67.96 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.367 -0.833 . . . . 0.0 109.424 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.589 ' HG3' ' N ' ' A' ' 8' ' ' ASN . 0.8 OUTLIER -64.2 -29.74 70.83 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.192 -0.943 . . . . 0.0 109.175 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.589 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 14.5 t-20 -63.57 -11.29 23.4 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.718 -1.238 . . . . 0.0 108.229 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 9' ' ' ILE . 39.6 mt -109.02 -8.65 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.462 -0.774 . . . . 0.0 109.861 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.511 HG22 ' HA ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -124.37 -42.99 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.555 ' N ' ' O ' ' A' ' 7' ' ' GLU . 13.8 t80 -45.11 -32.55 1.81 Allowed 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.029 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.82 -49.96 4.86 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.63 -35.23 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -1.179 . . . . 0.0 108.941 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -65.05 -45.47 85.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.359 -0.838 . . . . 0.0 109.113 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.474 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -57.64 -53.12 61.74 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.394 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 15' ' ' TYR . 1.5 m-20 -45.69 -30.8 1.68 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.01 -26.9 18.15 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.474 ' N ' ' O ' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -69.83 -44.7 69.42 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.56 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -69.06 -28.52 66.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 0.0 109.286 179.782 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -75.13 -12.02 60.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.3 -0.875 . . . . 0.0 109.324 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -100.85 -45.03 5.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.845 . . . . 0.0 109.432 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 48.0 t -71.77 -37.62 70.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 0.0 109.47 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 19' ' ' ARG . 73.1 t -63.02 -49.37 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.329 -0.857 . . . . 0.0 109.459 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.838 HD12 ' N ' ' A' ' 24' ' ' ILE . 2.7 mp -91.77 8.88 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.632 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 22' ' ' SER . 0.6 OUTLIER -49.91 147.42 3.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.572 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.069 -0.967 . . . . 0.0 109.469 -179.94 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 ttm . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 120.754 0.311 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.46 173.45 13.17 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.079 1.568 . . . . 0.0 110.561 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.44 67.34 1.77 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.54 -38.31 3.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.297 -1.12 . . . . 0.0 109.238 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.472 ' O ' HG13 ' A' ' 9' ' ' ILE . 34.2 mm -55.7 -46.89 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.312 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.436 ' HG3' ' N ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -60.99 -36.51 79.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.361 -0.837 . . . . 0.0 109.207 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 11' ' ' PHE . 2.1 mm-40 -70.17 -50.46 40.07 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.893 . . . . 0.0 108.963 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -48.16 -23.11 0.76 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 109.47 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 5' ' ' ILE . 18.2 mt -91.97 -13.36 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.302 -0.874 . . . . 0.0 109.866 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.55 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -119.07 -49.59 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.55 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -43.86 -36.28 2.3 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.57 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.99 -54.97 8.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.95 -47.34 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -61.6 -24.65 66.83 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.783 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.488 ' O ' ' N ' ' A' ' 18' ' ' TYR . 11.6 t80 -61.17 -57.72 11.29 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 15' ' ' TYR . 44.7 m-20 -45.36 -28.67 0.89 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -94.73 -26.18 16.38 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.526 ' N ' ' O ' ' A' ' 14' ' ' SER . 9.9 t80 -76.38 -41.22 48.73 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.876 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -45.6 -37.8 5.93 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.235 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 20' ' ' TYR . 1.5 t80 -68.49 -42.97 77.88 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 4.5 mtt85 -67.99 -27.44 66.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.452 -0.78 . . . . 0.0 109.362 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.4 t -79.87 -44.54 20.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.404 -0.81 . . . . 0.0 109.865 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 19' ' ' ARG . 42.1 t -57.87 -46.09 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.145 -0.972 . . . . 0.0 109.606 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.734 HD12 ' N ' ' A' ' 24' ' ' ILE . 3.2 mp -93.52 -13.22 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.906 . . . . 0.0 109.517 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.678 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 0.6 OUTLIER 42.38 84.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.745 179.734 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.678 ' HB3' ' O ' ' A' ' 25' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.524 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.566 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 121.53 0.681 . . . . 0.0 109.181 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.566 ' N ' ' CG2' ' A' ' 4' ' ' THR . 26.7 mm -67.27 -47.19 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.541 -0.725 . . . . 0.0 109.879 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 5' ' ' ILE . 30.1 tptt -45.19 -34.95 3.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.931 . . . . 0.0 109.058 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 11' ' ' PHE . 1.7 mt-10 -67.02 -47.46 71.35 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.398 -0.814 . . . . 0.0 108.815 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -55.51 -17.46 5.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.254 -0.904 . . . . 0.0 109.224 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.492 HG12 ' O ' ' A' ' 5' ' ' ILE . 6.5 mm -89.51 -14.34 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 109.226 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.496 HD13 ' HB ' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -114.66 -38.82 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.491 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.7 OUTLIER -52.61 -33.54 46.82 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.23 179.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.08 -41.11 40.82 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.496 ' HB ' HD13 ' A' ' 10' ' ' ILE . 76.2 t -59.07 -18.56 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.526 -0.985 . . . . 0.0 108.689 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 t -98.25 -52.19 3.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.486 -0.759 . . . . 0.0 109.227 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.575 ' CE2' ' HD2' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -60.42 -52.35 65.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.283 -0.885 . . . . 0.0 109.034 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 16' ' ' ASP . 3.5 m-20 -49.46 -25.13 2.39 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -87.74 -22.82 24.37 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 15' ' ' TYR . 7.4 m-85 -89.08 -27.83 20.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 109.498 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.575 ' HD2' ' CE2' ' A' ' 15' ' ' TYR . 32.8 mtp180 -95.74 -4.32 44.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.257 -0.902 . . . . 0.0 109.556 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 44.5 t80 -89.96 -40.46 12.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.55 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.69 -26.52 62.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.153 -0.967 . . . . 0.0 109.627 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.5 t -70.33 -58.89 3.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.393 -0.817 . . . . 0.0 109.926 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 90.2 t . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.233 -0.917 . . . . 0.0 110.113 -179.517 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.491 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.491 ' N ' ' CG2' ' A' ' 4' ' ' THR . 24.5 mt -49.89 -34.25 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.42 -0.8 . . . . 0.0 109.644 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -83.19 -24.44 32.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.629 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 11' ' ' PHE . 1.5 mm-40 -86.47 -47.16 9.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.934 . . . . 0.0 109.546 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -58.01 -14.1 5.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.224 -0.922 . . . . 0.0 109.669 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.483 ' O ' HG22 ' A' ' 9' ' ' ILE . 33.1 mt -103.48 -7.17 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.855 . . . . 0.0 109.683 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.519 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -120.84 -45.81 2.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.519 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -45.85 -36.32 5.18 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.32 -49.07 9.76 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 41.2 t -60.88 -40.09 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.424 -1.045 . . . . 0.0 109.015 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -57.84 -52.03 67.17 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.302 -0.874 . . . . 0.0 108.865 179.713 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.17 -55.21 27.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.417 -0.802 . . . . 0.0 108.85 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 20' ' ' TYR . 0.8 OUTLIER -51.35 -23.4 3.66 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.09 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 5.3 tt0 -97.95 -22.24 16.42 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.636 -0.665 . . . . 0.0 109.26 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -76.16 -30.72 58.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.098 -1.001 . . . . 0.0 109.455 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -106.26 10.7 31.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.335 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.415 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 72.8 t80 -119.57 -40.77 2.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.449 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.2 -42.33 55.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 109.5 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.5 t -52.44 -34.0 46.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.368 -0.832 . . . . 0.0 109.709 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 109.578 -179.908 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.41 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.49 ' O ' HG12 ' A' ' 9' ' ' ILE . 3.6 mt -88.35 -53.63 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.347 -0.846 . . . . 0.0 109.204 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 tmmt? -46.01 -25.57 0.58 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 109.482 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 11' ' ' PHE . 1.6 mm-40 -97.25 -47.99 5.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.902 . . . . 0.0 109.314 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -54.52 -17.91 3.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.371 -0.831 . . . . 0.0 109.434 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 5' ' ' ILE . 4.1 mm -103.73 -7.51 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -0.854 . . . . 0.0 109.652 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.554 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -122.72 -49.72 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.554 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.9 OUTLIER -48.48 -32.91 8.51 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.14 -46.86 8.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.8 t -57.28 -26.84 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -1.151 . . . . 0.0 109.156 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.5 t -79.02 -54.22 6.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.295 -0.878 . . . . 0.0 109.389 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.503 ' O ' ' N ' ' A' ' 18' ' ' TYR . 1.6 t80 -59.24 -55.04 39.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 108.782 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 15' ' ' TYR . 10.0 t0 -46.41 -26.66 0.88 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.35 -22.96 18.01 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.48 -0.763 . . . . 0.0 109.146 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 15' ' ' TYR . 0.6 OUTLIER -81.82 -25.83 34.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 109.543 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.23 -7.27 24.86 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.182 -0.949 . . . . 0.0 109.505 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.448 ' O ' HG12 ' A' ' 23' ' ' VAL . 58.8 t80 -106.4 -29.34 9.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.694 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -90.54 -44.93 9.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.045 -1.034 . . . . 0.0 109.537 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.5 t -49.5 -21.4 0.94 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.383 -0.823 . . . . 0.0 109.864 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 20' ' ' TYR . 11.5 p . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.107 -0.995 . . . . 0.0 109.77 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.418 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.418 ' N ' ' CG2' ' A' ' 4' ' ' THR . 3.5 mt -58.23 -50.7 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.595 -0.69 . . . . 0.0 109.616 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -51.61 -24.71 5.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 109.533 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 11' ' ' PHE . 0.9 OUTLIER -92.05 -47.92 7.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 109.685 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -63.22 -11.88 24.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.197 -0.939 . . . . 0.0 109.346 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.468 ' O ' HG22 ' A' ' 9' ' ' ILE . 14.2 mt -100.88 -12.42 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 109.512 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.596 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -108.87 -50.75 7.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.596 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -47.08 -38.94 12.12 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.478 ' N ' ' CD1' ' A' ' 11' ' ' PHE . . . -70.28 -38.07 71.26 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 9' ' ' ILE . 91.0 t -63.71 -45.67 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.232 -1.158 . . . . 0.0 109.041 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.9 t -54.61 -35.38 63.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.907 . . . . 0.0 109.125 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.489 ' O ' ' N ' ' A' ' 18' ' ' TYR . 2.4 t80 -71.83 -62.06 1.56 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.385 -0.822 . . . . 0.0 109.206 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 15' ' ' TYR . 74.6 m-20 -46.0 -26.61 0.75 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.213 -0.93 . . . . 0.0 108.623 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.82 -22.34 18.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.436 -0.79 . . . . 0.0 109.206 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.489 ' N ' ' O ' ' A' ' 15' ' ' TYR . 47.1 t80 -83.75 -52.3 6.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.953 . . . . 0.0 109.446 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.57 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -60.88 -37.07 80.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.106 -0.996 . . . . 0.0 109.22 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -59.34 -33.66 71.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.308 -0.87 . . . . 0.0 109.308 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.41 -28.3 66.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.621 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.6 t -83.57 -17.15 42.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 109.44 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 19' ' ' ARG . 61.4 t . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 109.283 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 5' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.493 ' O ' HG12 ' A' ' 9' ' ' ILE . 31.0 mm -68.8 -45.39 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.331 -0.856 . . . . 0.0 109.516 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -46.06 -34.38 4.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.143 -0.973 . . . . 0.0 108.797 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 11' ' ' PHE . 7.7 mm-40 -68.88 -59.08 3.31 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.376 -0.827 . . . . 0.0 109.116 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -54.89 -19.24 6.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 0.0 109.422 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 5' ' ' ILE . 4.2 mm -93.67 -10.88 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 109.452 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.455 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -113.83 -39.04 2.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 179.561 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -58.08 -30.42 66.22 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.834 179.381 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.69 -45.02 29.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.446 -1.862 . . . . 0.0 108.446 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.7 t -54.15 -23.59 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.419 -1.048 . . . . 0.0 108.289 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 t -94.47 -45.61 7.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.569 ' CD2' ' HD2' ' A' ' 19' ' ' ARG . 1.9 t80 -65.33 -57.75 7.61 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -49.3 -24.73 1.97 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -91.04 -24.63 20.0 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.481 ' N ' ' O ' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -80.34 -43.96 20.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.333 -0.854 . . . . 0.0 109.448 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.569 ' HD2' ' CD2' ' A' ' 15' ' ' TYR . 4.1 mtt180 -67.65 -20.31 65.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 109.639 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -76.26 -31.09 58.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.144 -0.973 . . . . 0.0 109.717 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.16 -40.75 15.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.289 -0.882 . . . . 0.0 109.672 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -69.11 -32.92 72.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 109.851 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.152 -0.968 . . . . 0.0 109.747 -179.799 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.542 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.542 ' N ' ' CG2' ' A' ' 4' ' ' THR . 87.0 mt -83.07 -47.16 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.504 -0.747 . . . . 0.0 109.438 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -48.19 -37.53 15.99 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.183 -0.948 . . . . 0.0 109.046 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.536 ' HG3' ' N ' ' A' ' 8' ' ' ASN . 14.9 pt-20 -82.7 -37.36 24.87 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.352 -0.843 . . . . 0.0 109.069 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.536 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 26.4 t30 -68.6 -6.86 28.08 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.311 -0.868 . . . . 0.0 108.728 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 5' ' ' ILE . 27.9 mt -104.65 -12.16 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.424 -0.798 . . . . 0.0 109.421 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.486 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.4 OUTLIER -107.49 -46.3 7.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.486 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -43.38 -31.32 0.65 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.15 -35.82 22.88 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 10' ' ' ILE . 60.0 t -79.6 -23.03 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.419 -1.048 . . . . 0.0 109.131 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.557 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 1.1 t -85.98 -41.46 14.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.252 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 18' ' ' TYR . 2.2 t80 -61.2 -56.78 16.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.24 -0.912 . . . . 0.0 108.585 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -49.5 -24.8 2.23 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.43 -23.47 18.39 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.557 ' CD1' ' O ' ' A' ' 14' ' ' SER . 8.3 m-30 -76.32 -59.24 2.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 0.0 109.641 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -18.88 52.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.934 . . . . 0.0 109.444 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.808 ' O ' HG12 ' A' ' 23' ' ' VAL . 43.8 t80 -78.47 -60.34 2.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 109.217 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.3 tmm_? -48.91 -38.11 21.78 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.1 t -56.7 -41.36 77.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.457 -0.777 . . . . 0.0 109.744 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.808 HG12 ' O ' ' A' ' 20' ' ' TYR . 2.9 p . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.113 -0.992 . . . . 0.0 109.439 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.507 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.507 ' N ' ' CG2' ' A' ' 4' ' ' THR . 2.3 mp -57.45 -51.86 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.524 -0.735 . . . . 0.0 109.213 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -47.42 -36.27 9.61 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.553 ' O ' ' N ' ' A' ' 11' ' ' PHE . 3.1 mt-10 -69.57 -45.73 68.0 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -49.47 -21.36 0.91 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.124 -0.985 . . . . 0.0 108.92 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.1 mt -93.83 -13.78 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.204 -0.935 . . . . 0.0 109.86 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.531 HG22 ' N ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -124.85 -52.23 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.553 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.9 OUTLIER -47.31 -28.96 2.21 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.25 -34.58 29.09 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' A' ' 10' ' ' ILE . 53.8 t -79.45 -26.13 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.488 -1.007 . . . . 0.0 109.027 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.4 OUTLIER -79.13 -30.69 43.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.446 -0.784 . . . . 0.0 109.161 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.449 ' HA ' ' HB3' ' A' ' 18' ' ' TYR . 2.4 t80 -69.76 -53.3 18.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.253 -0.905 . . . . 0.0 108.828 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.24 -26.47 11.87 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.14 -17.27 17.49 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 14' ' ' SER . 12.5 t80 -87.36 -55.73 3.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.379 -0.826 . . . . 0.0 109.391 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.454 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -46.55 -25.75 0.75 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.253 -0.904 . . . . 0.0 109.05 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -85.54 -34.01 21.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.316 -0.865 . . . . 0.0 109.068 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' A' ' 18' ' ' TYR . 1.7 ttp180 -81.18 -22.93 38.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.943 . . . . 0.0 109.447 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.6 t -69.55 -25.13 63.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.323 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 19' ' ' ARG . 3.8 t . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.364 -0.835 . . . . 0.0 109.406 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.34 -49.62 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.382 -0.824 . . . . 0.0 109.341 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -57.03 -37.0 71.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -0.876 . . . . 0.0 109.272 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 11' ' ' PHE . 5.1 mm-40 -61.66 -50.93 70.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.875 . . . . 0.0 109.145 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -51.15 -20.36 1.48 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.906 -1.121 . . . . 0.0 109.014 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.45 ' O ' HG22 ' A' ' 9' ' ' ILE . 33.6 mt -108.1 -7.66 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 110.385 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -126.71 -41.25 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.084 -1.01 . . . . 0.0 108.51 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.559 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -47.72 -31.61 4.92 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.541 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.34 -44.31 6.63 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 92.0 t -72.12 -21.0 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.431 -1.04 . . . . 0.0 108.929 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.57 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -82.5 -49.17 10.2 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.489 ' CZ ' ' HG3' ' A' ' 19' ' ' ARG . 4.7 t80 -52.94 -50.51 63.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 108.772 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -53.63 -19.72 4.33 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.44 ' O ' ' NH1' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -117.97 -0.12 11.75 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.329 -0.857 . . . . 0.0 109.536 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.57 ' N ' ' O ' ' A' ' 14' ' ' SER . 7.2 t80 -104.99 -59.19 1.78 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.105 -0.997 . . . . 0.0 109.948 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.561 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -49.75 -30.52 9.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.146 -0.971 . . . . 0.0 109.509 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -75.16 -48.75 22.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.492 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.44 ' NH1' ' O ' ' A' ' 17' ' ' GLU . 19.9 mtm-85 -71.03 -34.92 71.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.368 -0.833 . . . . 0.0 109.525 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.2 t -59.09 -15.35 13.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.192 -0.942 . . . . 0.0 109.467 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 19' ' ' ARG . 48.9 t . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.473 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.443 0.639 . . . . 0.0 109.316 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.518 ' O ' HG12 ' A' ' 9' ' ' ILE . 4.0 mt -56.17 -52.6 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.318 -0.864 . . . . 0.0 109.622 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.501 ' HG3' ' HG2' ' A' ' 7' ' ' GLU . 12.8 pttm -43.76 -28.87 0.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.417 -0.802 . . . . 0.0 109.525 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.501 ' HG2' ' HG3' ' A' ' 6' ' ' LYS . 3.9 mm-40 -85.58 -49.43 8.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.44 -0.787 . . . . 0.0 109.704 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -59.64 -14.29 13.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 0.0 109.657 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 5' ' ' ILE . 14.6 mm -91.71 -15.27 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 109.283 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.602 HG22 ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -115.21 -55.82 4.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.602 ' N ' HG22 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -46.8 -28.17 1.46 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 16' ' ' ASP . . . -75.57 -45.21 18.68 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 58.1 t -54.37 -20.27 4.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.561 -0.964 . . . . 0.0 108.548 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.451 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 0.4 OUTLIER -103.17 -51.23 3.29 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.71 -0.619 . . . . 0.0 109.482 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.454 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.3 OUTLIER -72.02 -60.31 2.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -0.928 . . . . 0.0 109.439 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.54 ' O ' ' CB ' ' A' ' 20' ' ' TYR . 4.2 m-20 -50.39 -21.83 1.6 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.047 -1.033 . . . . 0.0 108.485 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -96.29 -17.37 20.77 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.383 -0.823 . . . . 0.0 109.266 179.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.454 ' N ' ' O ' ' A' ' 15' ' ' TYR . 1.1 m-85 -99.05 -41.75 7.41 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.192 -0.943 . . . . 0.0 110.68 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.2 -4.35 54.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.009 -1.057 . . . . 0.0 110.426 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.54 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 22.7 t80 -95.42 -72.72 0.61 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.997 -1.064 . . . . 0.0 109.656 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.02 -31.3 2.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.278 -0.889 . . . . 0.0 109.325 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.4 t -61.83 -14.81 36.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.37 -0.832 . . . . 0.0 109.883 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.154 -0.966 . . . . 0.0 109.732 -179.86 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.493 ' O ' ' HG2' ' A' ' 7' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.416 HG13 HG22 ' A' ' 4' ' ' THR . 69.4 mt -83.11 -44.47 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.457 -0.777 . . . . 0.0 109.526 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -46.71 -34.5 5.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.873 . . . . 0.0 109.214 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 11' ' ' PHE . 13.2 pt-20 -86.12 -39.87 16.27 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.3 -0.875 . . . . 0.0 108.728 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.54 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 7.2 t-20 -54.29 -17.72 3.24 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.975 -1.078 . . . . 0.0 108.202 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.404 ' N ' ' C ' ' A' ' 7' ' ' GLU . 6.8 mm -98.23 -15.5 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.47 -0.769 . . . . 0.0 109.602 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.577 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -121.96 -52.32 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.577 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 1.6 t80 -51.63 -28.1 13.36 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.64 -38.89 13.01 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.1 t -71.64 -32.51 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -1.103 . . . . 0.0 108.832 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 18' ' ' TYR . 8.2 t -66.38 -39.11 88.89 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.265 -0.897 . . . . 0.0 108.899 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.454 ' O ' ' N ' ' A' ' 18' ' ' TYR . 2.4 t80 -62.25 -55.14 31.32 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.289 -0.882 . . . . 0.0 108.817 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 15' ' ' TYR . 93.5 m-20 -46.73 -30.77 2.56 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -90.17 -27.89 19.27 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.456 ' N ' ' O ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -72.44 -37.56 68.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.315 -0.866 . . . . 0.0 109.011 179.6 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 1.032 ' O ' HG23 ' A' ' 23' ' ' VAL . 4.1 mtm180 -77.01 -44.13 32.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.063 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.547 ' CD1' ' C ' ' A' ' 20' ' ' TYR . 6.2 t80 -49.48 -26.25 3.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.363 -0.836 . . . . 0.0 108.984 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -77.61 -51.6 10.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.375 -0.828 . . . . 0.0 109.236 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -67.25 -12.99 61.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.881 . . . . 0.0 109.305 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.032 HG23 ' O ' ' A' ' 19' ' ' ARG . 14.3 t . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.218 -0.926 . . . . 0.0 109.612 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.407 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.478 ' O ' HG12 ' A' ' 9' ' ' ILE . 42.1 mm -47.75 -37.12 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.443 -0.786 . . . . 0.0 109.147 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -77.25 -52.31 9.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.378 -0.826 . . . . 0.0 109.142 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 11' ' ' PHE . 1.1 mm-40 -59.29 -42.88 92.31 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.271 -0.893 . . . . 0.0 109.043 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -46.6 -23.82 0.45 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.068 -1.02 . . . . 0.0 109.275 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 5' ' ' ILE . 4.1 mm -97.57 -15.74 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.827 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.4 OUTLIER -120.55 -52.11 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.106 -0.996 . . . . 0.0 108.589 179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.573 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -42.17 -32.36 0.47 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.6 -45.3 13.76 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.87 -32.02 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.436 -1.038 . . . . 0.0 108.824 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.5 -32.56 54.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.405 -0.809 . . . . 0.0 109.018 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.468 ' HB2' ' O ' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -62.48 -53.31 56.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -0.846 . . . . 0.0 108.861 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.0 -22.87 2.52 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -99.39 -17.17 18.13 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.466 -0.771 . . . . 0.0 109.267 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.93 -54.07 4.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 0.0 109.829 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.876 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -56.73 -25.26 54.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 110.02 -179.553 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -68.95 -45.0 71.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.188 -0.945 . . . . 0.0 109.957 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.17 -33.47 67.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.92 . . . . 0.0 109.834 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.7 t -74.67 -4.49 37.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 0.0 110.163 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 19' ' ' ARG . 61.3 t . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.04 -1.037 . . . . 0.0 110.078 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.556 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.412 0.625 . . . . 0.0 109.395 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.556 ' N ' ' CG2' ' A' ' 4' ' ' THR . 22.2 mm -53.89 -40.02 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.431 -0.793 . . . . 0.0 109.655 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -61.82 -51.51 67.96 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.367 -0.833 . . . . 0.0 109.424 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.589 ' HG3' ' N ' ' A' ' 8' ' ' ASN . 0.8 OUTLIER -64.2 -29.74 70.83 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.192 -0.943 . . . . 0.0 109.175 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.589 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 1.8 t30 -63.57 -11.29 23.4 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.718 -1.238 . . . . 0.0 108.229 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.493 ' O ' HG22 ' A' ' 9' ' ' ILE . 39.6 mt -109.02 -8.65 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.462 -0.774 . . . . 0.0 109.861 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.511 HG22 ' HA ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -124.37 -42.99 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.555 ' N ' ' O ' ' A' ' 7' ' ' GLU . 13.8 t80 -45.11 -32.55 1.81 Allowed 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.029 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.82 -49.96 4.86 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.63 -35.23 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -1.179 . . . . 0.0 108.941 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -65.05 -45.47 85.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.359 -0.838 . . . . 0.0 109.113 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.474 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -57.64 -53.12 61.74 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.394 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 15' ' ' TYR . 1.5 m-20 -45.69 -30.8 1.68 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.01 -26.9 18.15 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.474 ' N ' ' O ' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -69.83 -44.7 69.42 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.56 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -69.06 -28.52 66.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 0.0 109.286 179.782 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -75.13 -12.02 60.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.3 -0.875 . . . . 0.0 109.324 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -100.85 -45.03 5.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.845 . . . . 0.0 109.432 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.0 t -71.77 -37.62 70.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 0.0 109.47 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 19' ' ' ARG . 73.1 t . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.329 -0.857 . . . . 0.0 109.459 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.472 ' O ' HG13 ' A' ' 9' ' ' ILE . 34.2 mm -55.7 -46.89 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.312 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.436 ' HG3' ' N ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -60.99 -36.51 79.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.361 -0.837 . . . . 0.0 109.207 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 11' ' ' PHE . 2.1 mm-40 -70.17 -50.46 40.07 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.893 . . . . 0.0 108.963 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -48.16 -23.11 0.76 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 109.47 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 5' ' ' ILE . 18.2 mt -91.97 -13.36 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.302 -0.874 . . . . 0.0 109.866 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.55 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -119.07 -49.59 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.55 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -43.86 -36.28 2.3 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.57 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.99 -54.97 8.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.95 -47.34 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -61.6 -24.65 66.83 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.488 ' O ' ' N ' ' A' ' 18' ' ' TYR . 11.6 t80 -61.17 -57.72 11.29 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 15' ' ' TYR . 44.7 m-20 -45.36 -28.67 0.89 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -94.73 -26.18 16.38 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.526 ' N ' ' O ' ' A' ' 14' ' ' SER . 9.9 t80 -76.38 -41.22 48.73 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.876 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -45.6 -37.8 5.93 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.235 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 20' ' ' TYR . 1.5 t80 -68.49 -42.97 77.88 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -67.99 -27.44 66.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.452 -0.78 . . . . 0.0 109.362 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.4 t -79.87 -44.54 20.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.404 -0.81 . . . . 0.0 109.865 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 19' ' ' ARG . 42.1 t . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.145 -0.972 . . . . 0.0 109.606 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.5 72.36 3.65 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.881 1.463 . . . . 0.0 110.449 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -127.87 25.92 4.89 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.566 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -56.83 -49.51 75.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.353 -1.086 . . . . 0.0 109.181 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.566 ' N ' ' CG2' ' A' ' 4' ' ' THR . 26.7 mm -67.27 -47.19 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.541 -0.725 . . . . 0.0 109.879 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 5' ' ' ILE . 30.1 tptt -45.19 -34.95 3.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.931 . . . . 0.0 109.058 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 11' ' ' PHE . 1.7 mt-10 -67.02 -47.46 71.35 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.398 -0.814 . . . . 0.0 108.815 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -55.51 -17.46 5.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.254 -0.904 . . . . 0.0 109.224 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.492 HG12 ' O ' ' A' ' 5' ' ' ILE . 6.5 mm -89.51 -14.34 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 109.226 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.496 HD13 ' HB ' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -114.66 -38.82 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.491 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.7 OUTLIER -52.61 -33.54 46.82 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.23 179.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.08 -41.11 40.82 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.496 ' HB ' HD13 ' A' ' 10' ' ' ILE . 76.2 t -59.07 -18.56 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.526 -0.985 . . . . 0.0 108.689 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 t -98.25 -52.19 3.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.486 -0.759 . . . . 0.0 109.227 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.575 ' CE2' ' HD2' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -60.42 -52.35 65.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.283 -0.885 . . . . 0.0 109.034 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 16' ' ' ASP . 3.5 m-20 -49.46 -25.13 2.39 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -87.74 -22.82 24.37 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 15' ' ' TYR . 7.4 m-85 -89.08 -27.83 20.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 109.498 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.575 ' HD2' ' CE2' ' A' ' 15' ' ' TYR . 32.8 mtp180 -95.74 -4.32 44.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.257 -0.902 . . . . 0.0 109.556 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 44.5 t80 -89.96 -40.46 12.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.55 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.69 -26.52 62.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.153 -0.967 . . . . 0.0 109.627 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.5 t -70.33 -58.89 3.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.393 -0.817 . . . . 0.0 109.926 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.556 ' C ' HD12 ' A' ' 24' ' ' ILE . 90.2 t -58.49 -35.23 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.233 -0.917 . . . . 0.0 110.113 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.774 HG22 ' O ' ' A' ' 24' ' ' ILE . 1.7 mp -98.41 16.69 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.138 -0.976 . . . . 0.0 109.378 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -64.95 107.48 1.5 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.053 -1.029 . . . . 0.0 109.638 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 25' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.585 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.778 0.323 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -75.57 70.36 5.7 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.103 1.581 . . . . 0.0 110.424 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -127.68 14.9 6.35 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.491 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -62.66 -46.54 87.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -1.145 . . . . 0.0 109.299 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.491 ' N ' ' CG2' ' A' ' 4' ' ' THR . 24.5 mt -49.89 -34.25 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.42 -0.8 . . . . 0.0 109.644 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -83.19 -24.44 32.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.629 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 11' ' ' PHE . 1.5 mm-40 -86.47 -47.16 9.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.934 . . . . 0.0 109.546 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -58.01 -14.1 5.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.224 -0.922 . . . . 0.0 109.669 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.483 ' O ' HG22 ' A' ' 9' ' ' ILE . 33.1 mt -103.48 -7.17 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.855 . . . . 0.0 109.683 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.519 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -120.84 -45.81 2.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.519 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -45.85 -36.32 5.18 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.32 -49.07 9.76 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 41.2 t -60.88 -40.09 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.424 -1.045 . . . . 0.0 109.015 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -57.84 -52.03 67.17 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.302 -0.874 . . . . 0.0 108.865 179.713 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.17 -55.21 27.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.417 -0.802 . . . . 0.0 108.85 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 20' ' ' TYR . 0.8 OUTLIER -51.35 -23.4 3.66 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.09 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 5.3 tt0 -97.95 -22.24 16.42 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.636 -0.665 . . . . 0.0 109.26 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -76.16 -30.72 58.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.098 -1.001 . . . . 0.0 109.455 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -106.26 10.7 31.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.335 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.481 ' CE2' HG21 ' A' ' 24' ' ' ILE . 72.8 t80 -119.57 -40.77 2.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.449 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.515 ' O ' ' N ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -75.2 -42.33 55.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 109.5 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.5 t -52.44 -34.0 46.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.368 -0.832 . . . . 0.0 109.709 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.539 HG13 ' N ' ' A' ' 24' ' ' ILE . 8.7 p -92.98 -41.08 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 109.578 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.586 HG23 ' O ' ' A' ' 24' ' ' ILE . 1.5 tp -88.56 11.22 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.346 -0.846 . . . . 0.0 109.985 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.624 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -64.21 -170.14 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.007 -1.058 . . . . 0.0 109.136 179.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 25' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.643 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.723 0.297 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.25 165.1 33.52 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.057 1.556 . . . . 0.0 110.552 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 117.0 27.4 2.72 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.41 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -116.63 -44.73 2.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.363 -1.081 . . . . 0.0 108.913 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.49 ' O ' HG12 ' A' ' 9' ' ' ILE . 3.6 mt -88.35 -53.63 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.347 -0.846 . . . . 0.0 109.204 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 tmmt? -46.01 -25.57 0.58 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 109.482 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 11' ' ' PHE . 1.6 mm-40 -97.25 -47.99 5.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.902 . . . . 0.0 109.314 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -54.52 -17.91 3.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.371 -0.831 . . . . 0.0 109.434 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 5' ' ' ILE . 4.1 mm -103.73 -7.51 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -0.854 . . . . 0.0 109.652 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.554 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -122.72 -49.72 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.554 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.9 OUTLIER -48.48 -32.91 8.51 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.14 -46.86 8.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.8 t -57.28 -26.84 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -1.151 . . . . 0.0 109.156 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.5 t -79.02 -54.22 6.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.295 -0.878 . . . . 0.0 109.389 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.503 ' O ' ' N ' ' A' ' 18' ' ' TYR . 1.6 t80 -59.24 -55.04 39.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 108.782 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 15' ' ' TYR . 10.0 t0 -46.41 -26.66 0.88 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.35 -22.96 18.01 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.48 -0.763 . . . . 0.0 109.146 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 15' ' ' TYR . 0.6 OUTLIER -81.82 -25.83 34.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 109.543 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.23 -7.27 24.86 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.182 -0.949 . . . . 0.0 109.505 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.499 ' O ' HG12 ' A' ' 24' ' ' ILE . 58.8 t80 -106.4 -29.34 9.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.694 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -90.54 -44.93 9.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.045 -1.034 . . . . 0.0 109.537 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.5 t -49.5 -21.4 0.94 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.383 -0.823 . . . . 0.0 109.864 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.538 HG13 ' N ' ' A' ' 24' ' ' ILE . 11.5 p -92.63 -42.83 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.107 -0.995 . . . . 0.0 109.77 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.538 ' N ' HG13 ' A' ' 23' ' ' VAL . 22.9 mm -76.66 -26.78 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.222 -0.923 . . . . 0.0 109.77 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 26' ' ' ALA . 22.7 tttt -57.79 -54.98 40.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.152 -0.968 . . . . 0.0 109.425 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 25' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.48 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.816 0.341 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.64 -168.02 0.37 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.988 1.52 . . . . 0.0 110.323 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 99.25 -19.13 55.25 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.418 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -81.92 -42.05 20.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -1.144 . . . . 0.0 109.037 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.418 ' N ' ' CG2' ' A' ' 4' ' ' THR . 3.5 mt -58.23 -50.7 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.595 -0.69 . . . . 0.0 109.616 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -51.61 -24.71 5.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 109.533 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 11' ' ' PHE . 0.9 OUTLIER -92.05 -47.92 7.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 109.685 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -63.22 -11.88 24.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.197 -0.939 . . . . 0.0 109.346 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.468 ' O ' HG22 ' A' ' 9' ' ' ILE . 14.2 mt -100.88 -12.42 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 109.512 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.596 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -108.87 -50.75 7.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.596 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -47.08 -38.94 12.12 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.478 ' N ' ' CD1' ' A' ' 11' ' ' PHE . . . -70.28 -38.07 71.26 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 9' ' ' ILE . 91.0 t -63.71 -45.67 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.232 -1.158 . . . . 0.0 109.041 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.9 t -54.61 -35.38 63.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.907 . . . . 0.0 109.125 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.489 ' O ' ' N ' ' A' ' 18' ' ' TYR . 2.4 t80 -71.83 -62.06 1.56 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.385 -0.822 . . . . 0.0 109.206 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 15' ' ' TYR . 74.6 m-20 -46.0 -26.61 0.75 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.213 -0.93 . . . . 0.0 108.623 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.82 -22.34 18.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.436 -0.79 . . . . 0.0 109.206 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.489 ' N ' ' O ' ' A' ' 15' ' ' TYR . 47.1 t80 -83.75 -52.3 6.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.953 . . . . 0.0 109.446 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.57 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -60.88 -37.07 80.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.106 -0.996 . . . . 0.0 109.22 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -59.34 -33.66 71.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.308 -0.87 . . . . 0.0 109.308 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.41 -28.3 66.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.621 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.6 t -83.57 -17.15 42.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 109.44 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 19' ' ' ARG . 61.4 t -76.69 -34.44 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 109.283 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.757 HD12 ' N ' ' A' ' 24' ' ' ILE . 2.6 mp -104.95 -24.19 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.362 -0.836 . . . . 0.0 109.153 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.515 ' HG3' ' N ' ' A' ' 26' ' ' ALA . 7.8 tptt 40.81 -94.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.554 -0.716 . . . . 0.0 109.839 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.515 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.105 -0.997 . . . . 0.0 109.427 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 120.864 0.364 . . . . 0.0 110.094 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -78.14 169.07 20.92 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.131 1.595 . . . . 0.0 110.199 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 59.33 15.23 30.17 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -119.22 -48.05 2.44 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -1.121 . . . . 0.0 109.018 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.493 ' O ' HG12 ' A' ' 9' ' ' ILE . 31.0 mm -68.8 -45.39 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.331 -0.856 . . . . 0.0 109.516 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -46.06 -34.38 4.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.143 -0.973 . . . . 0.0 108.797 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 11' ' ' PHE . 7.7 mm-40 -68.88 -59.08 3.31 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.376 -0.827 . . . . 0.0 109.116 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -54.89 -19.24 6.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 0.0 109.422 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 5' ' ' ILE . 4.2 mm -93.67 -10.88 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 109.452 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.455 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -113.83 -39.04 2.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 179.561 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -58.08 -30.42 66.22 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.834 179.381 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.69 -45.02 29.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.446 -1.862 . . . . 0.0 108.446 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.7 t -54.15 -23.59 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.419 -1.048 . . . . 0.0 108.289 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 t -94.47 -45.61 7.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.569 ' CD2' ' HD2' ' A' ' 19' ' ' ARG . 1.9 t80 -65.33 -57.75 7.61 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -49.3 -24.73 1.97 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -91.04 -24.63 20.0 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.481 ' N ' ' O ' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -80.34 -43.96 20.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.333 -0.854 . . . . 0.0 109.448 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.569 ' HD2' ' CD2' ' A' ' 15' ' ' TYR . 4.1 mtt180 -67.65 -20.31 65.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 109.639 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -76.26 -31.09 58.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.144 -0.973 . . . . 0.0 109.717 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.524 ' O ' ' CA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -86.16 -40.75 15.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.289 -0.882 . . . . 0.0 109.672 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -69.11 -32.92 72.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 109.851 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.774 HG13 HD12 ' A' ' 24' ' ' ILE . 7.6 p -74.13 -46.46 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.152 -0.968 . . . . 0.0 109.747 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.804 HG22 ' O ' ' A' ' 24' ' ' ILE . 3.4 mt -123.45 44.32 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 109.173 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.524 ' CA ' ' O ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -45.48 -29.41 1.13 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.253 -0.905 . . . . 0.0 109.578 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.481 -179.946 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.411 ' HA ' ' HD2' ' A' ' 2' ' ' PRO . 4.6 mtt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 120.834 0.35 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 46.1 Cg_endo -72.95 -174.66 1.61 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.059 1.557 . . . . 0.0 110.51 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 88.93 54.28 2.36 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.542 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -108.33 -49.43 3.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.314 -1.109 . . . . 0.0 109.058 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.542 ' N ' ' CG2' ' A' ' 4' ' ' THR . 87.0 mt -83.07 -47.16 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.504 -0.747 . . . . 0.0 109.438 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -48.19 -37.53 15.99 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.183 -0.948 . . . . 0.0 109.046 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.536 ' HG3' ' N ' ' A' ' 8' ' ' ASN . 14.9 pt-20 -82.7 -37.36 24.87 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.352 -0.843 . . . . 0.0 109.069 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.536 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 26.4 t30 -68.6 -6.86 28.08 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.311 -0.868 . . . . 0.0 108.728 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 5' ' ' ILE . 27.9 mt -104.65 -12.16 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.424 -0.798 . . . . 0.0 109.421 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.486 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.4 OUTLIER -107.49 -46.3 7.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.486 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -43.38 -31.32 0.65 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.15 -35.82 22.88 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 10' ' ' ILE . 60.0 t -79.6 -23.03 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.419 -1.048 . . . . 0.0 109.131 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.557 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 1.1 t -85.98 -41.46 14.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.252 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 18' ' ' TYR . 2.2 t80 -61.2 -56.78 16.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.24 -0.912 . . . . 0.0 108.585 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -49.5 -24.8 2.23 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.43 -23.47 18.39 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.557 ' CD1' ' O ' ' A' ' 14' ' ' SER . 8.3 m-30 -76.32 -59.24 2.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 0.0 109.641 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -18.88 52.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.934 . . . . 0.0 109.444 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.808 ' O ' HG12 ' A' ' 23' ' ' VAL . 43.8 t80 -78.47 -60.34 2.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 109.217 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.3 tmm_? -48.91 -38.11 21.78 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.1 t -56.7 -41.36 77.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.457 -0.777 . . . . 0.0 109.744 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.843 HG13 HD13 ' A' ' 24' ' ' ILE . 2.9 p -72.05 -27.46 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.113 -0.992 . . . . 0.0 109.439 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.843 HD13 HG13 ' A' ' 23' ' ' VAL . 8.9 mm -91.58 2.47 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.386 -0.821 . . . . 0.0 109.536 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.99 -47.7 9.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 109.526 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.387 -179.891 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.873 0.368 . . . . 0.0 110.324 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.5 164.82 34.03 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.006 1.53 . . . . 0.0 110.402 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.8 44.06 21.06 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.507 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -121.92 -47.17 2.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.306 -1.114 . . . . 0.0 109.229 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.507 ' N ' ' CG2' ' A' ' 4' ' ' THR . 2.3 mp -57.45 -51.86 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.524 -0.735 . . . . 0.0 109.213 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -47.42 -36.27 9.61 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.553 ' O ' ' N ' ' A' ' 11' ' ' PHE . 3.1 mt-10 -69.57 -45.73 68.0 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -49.47 -21.36 0.91 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.124 -0.985 . . . . 0.0 108.92 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.1 mt -93.83 -13.78 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.204 -0.935 . . . . 0.0 109.86 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.531 HG22 ' N ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -124.85 -52.23 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.553 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.9 OUTLIER -47.31 -28.96 2.21 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.25 -34.58 29.09 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' A' ' 10' ' ' ILE . 53.8 t -79.45 -26.13 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.488 -1.007 . . . . 0.0 109.027 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.4 OUTLIER -79.13 -30.69 43.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.446 -0.784 . . . . 0.0 109.161 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.449 ' HA ' ' HB3' ' A' ' 18' ' ' TYR . 2.4 t80 -69.76 -53.3 18.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.253 -0.905 . . . . 0.0 108.828 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.24 -26.47 11.87 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.14 -17.27 17.49 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 14' ' ' SER . 12.5 t80 -87.36 -55.73 3.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.379 -0.826 . . . . 0.0 109.391 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.454 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -46.55 -25.75 0.75 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.253 -0.904 . . . . 0.0 109.05 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -85.54 -34.01 21.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.316 -0.865 . . . . 0.0 109.068 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 25' ' ' LYS . 1.7 ttp180 -81.18 -22.93 38.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.943 . . . . 0.0 109.447 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.6 t -69.55 -25.13 63.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.323 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.673 ' HB ' HD12 ' A' ' 24' ' ' ILE . 3.8 t -88.12 -18.99 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.364 -0.835 . . . . 0.0 109.406 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.768 HG22 ' O ' ' A' ' 24' ' ' ILE . 4.5 mp -142.8 38.61 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.409 -0.807 . . . . 0.0 109.448 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 21' ' ' ARG . 59.4 tttm -54.0 -71.93 0.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.16 -0.963 . . . . 0.0 109.448 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.099 -0.953 . . . . 0.0 109.507 179.935 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mtm . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 120.749 0.309 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.86 63.03 4.89 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.903 1.475 . . . . 0.0 110.597 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -132.97 35.13 2.35 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.57 -37.39 9.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -1.076 . . . . 0.0 109.237 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.34 -49.62 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.382 -0.824 . . . . 0.0 109.341 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -57.03 -37.0 71.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -0.876 . . . . 0.0 109.272 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 11' ' ' PHE . 5.1 mm-40 -61.66 -50.93 70.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.875 . . . . 0.0 109.145 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -51.15 -20.36 1.48 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.906 -1.121 . . . . 0.0 109.014 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.45 ' O ' HG22 ' A' ' 9' ' ' ILE . 33.6 mt -108.1 -7.66 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 110.385 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -126.71 -41.25 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.084 -1.01 . . . . 0.0 108.51 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.559 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -47.72 -31.61 4.92 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.541 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.34 -44.31 6.63 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 92.0 t -72.12 -21.0 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.431 -1.04 . . . . 0.0 108.929 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.57 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -82.5 -49.17 10.2 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.489 ' CZ ' ' HG3' ' A' ' 19' ' ' ARG . 4.7 t80 -52.94 -50.51 63.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 108.772 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -53.63 -19.72 4.33 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.44 ' O ' ' NH1' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -117.97 -0.12 11.75 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.329 -0.857 . . . . 0.0 109.536 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.57 ' N ' ' O ' ' A' ' 14' ' ' SER . 7.2 t80 -104.99 -59.19 1.78 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.105 -0.997 . . . . 0.0 109.948 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.561 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -49.75 -30.52 9.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.146 -0.971 . . . . 0.0 109.509 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -75.16 -48.75 22.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.492 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 25' ' ' LYS . 19.9 mtm-85 -71.03 -34.92 71.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.368 -0.833 . . . . 0.0 109.525 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.2 t -59.09 -15.35 13.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.192 -0.942 . . . . 0.0 109.467 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.601 ' HB ' HD12 ' A' ' 24' ' ' ILE . 48.9 t -98.58 -40.83 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.473 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.601 HD12 ' HB ' ' A' ' 23' ' ' VAL . 3.8 mp -123.74 36.53 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.794 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 21' ' ' ARG . 7.3 tttt -58.61 112.55 1.65 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.167 -0.958 . . . . 0.0 109.41 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 25' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.38 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttm . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 120.892 0.377 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.43 172.64 15.27 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.109 1.584 . . . . 0.0 110.531 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 53.08 32.27 42.35 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.94 -36.41 0.61 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.335 -1.097 . . . . 0.0 109.316 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.518 ' O ' HG12 ' A' ' 9' ' ' ILE . 4.0 mt -56.17 -52.6 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.318 -0.864 . . . . 0.0 109.622 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.501 ' HG3' ' HG2' ' A' ' 7' ' ' GLU . 12.8 pttm -43.76 -28.87 0.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.417 -0.802 . . . . 0.0 109.525 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.501 ' HG2' ' HG3' ' A' ' 6' ' ' LYS . 3.9 mm-40 -85.58 -49.43 8.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.44 -0.787 . . . . 0.0 109.704 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -59.64 -14.29 13.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 0.0 109.657 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 5' ' ' ILE . 14.6 mm -91.71 -15.27 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 109.283 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.602 HG22 ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -115.21 -55.82 4.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.602 ' N ' HG22 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -46.8 -28.17 1.46 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 16' ' ' ASP . . . -75.57 -45.21 18.68 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 58.1 t -54.37 -20.27 4.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.561 -0.964 . . . . 0.0 108.548 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.451 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 0.4 OUTLIER -103.17 -51.23 3.29 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.71 -0.619 . . . . 0.0 109.482 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.454 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.3 OUTLIER -72.02 -60.31 2.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -0.928 . . . . 0.0 109.439 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.54 ' O ' ' CB ' ' A' ' 20' ' ' TYR . 4.2 m-20 -50.39 -21.83 1.6 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.047 -1.033 . . . . 0.0 108.485 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -96.29 -17.37 20.77 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.383 -0.823 . . . . 0.0 109.266 179.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.454 ' N ' ' O ' ' A' ' 15' ' ' TYR . 1.1 m-85 -99.05 -41.75 7.41 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.192 -0.943 . . . . 0.0 110.68 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.2 -4.35 54.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.009 -1.057 . . . . 0.0 110.426 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.54 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 22.7 t80 -95.42 -72.72 0.61 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.997 -1.064 . . . . 0.0 109.656 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -46.02 -31.3 2.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.278 -0.889 . . . . 0.0 109.325 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.4 t -61.83 -14.81 36.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.37 -0.832 . . . . 0.0 109.883 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.546 ' C ' HD12 ' A' ' 24' ' ' ILE . 10.0 t -114.18 -21.81 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.154 -0.966 . . . . 0.0 109.732 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.644 ' N ' HD12 ' A' ' 24' ' ' ILE . 1.5 mp -97.09 -29.51 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 0.0 109.703 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -143.91 139.11 29.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.176 -0.952 . . . . 0.0 109.717 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.388 179.867 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 mtt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.79 153.84 43.15 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.865 1.455 . . . . 0.0 110.391 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 55.39 51.68 52.8 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.493 ' O ' ' HG2' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -121.67 -36.45 3.04 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.281 -1.129 . . . . 0.0 108.834 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.416 HG13 HG22 ' A' ' 4' ' ' THR . 69.4 mt -83.11 -44.47 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.457 -0.777 . . . . 0.0 109.526 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -46.71 -34.5 5.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.873 . . . . 0.0 109.214 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 11' ' ' PHE . 13.2 pt-20 -86.12 -39.87 16.27 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.3 -0.875 . . . . 0.0 108.728 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.54 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 7.2 t-20 -54.29 -17.72 3.24 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.975 -1.078 . . . . 0.0 108.202 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.404 ' N ' ' C ' ' A' ' 7' ' ' GLU . 6.8 mm -98.23 -15.5 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.47 -0.769 . . . . 0.0 109.602 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.577 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -121.96 -52.32 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.577 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 1.6 t80 -51.63 -28.1 13.36 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.64 -38.89 13.01 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.1 t -71.64 -32.51 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -1.103 . . . . 0.0 108.832 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 18' ' ' TYR . 8.2 t -66.38 -39.11 88.89 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.265 -0.897 . . . . 0.0 108.899 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.454 ' O ' ' N ' ' A' ' 18' ' ' TYR . 2.4 t80 -62.25 -55.14 31.32 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.289 -0.882 . . . . 0.0 108.817 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 15' ' ' TYR . 93.5 m-20 -46.73 -30.77 2.56 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -90.17 -27.89 19.27 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.456 ' N ' ' O ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -72.44 -37.56 68.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.315 -0.866 . . . . 0.0 109.011 179.6 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 1.032 ' O ' HG23 ' A' ' 23' ' ' VAL . 4.1 mtm180 -77.01 -44.13 32.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.063 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.547 ' C ' ' CD1' ' A' ' 20' ' ' TYR . 6.2 t80 -49.48 -26.25 3.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.363 -0.836 . . . . 0.0 108.984 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 25' ' ' LYS . 1.9 ttp180 -77.61 -51.6 10.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.375 -0.828 . . . . 0.0 109.236 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -67.25 -12.99 61.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.881 . . . . 0.0 109.305 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.032 HG23 ' O ' ' A' ' 19' ' ' ARG . 14.3 t -89.0 -24.26 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.218 -0.926 . . . . 0.0 109.612 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.754 HD12 ' C ' ' A' ' 23' ' ' VAL . 2.2 mp -121.37 -0.67 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.954 . . . . 0.0 109.526 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -133.98 72.01 1.47 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.185 -0.947 . . . . 0.0 109.425 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.56 -179.85 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HA ' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.821 0.343 . . . . 0.0 110.166 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 45.2 Cg_endo -72.29 178.95 5.47 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.912 1.48 . . . . 0.0 110.525 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 79.71 52.56 4.66 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.407 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -137.88 -42.79 0.53 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -1.13 . . . . 0.0 109.167 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.478 ' O ' HG12 ' A' ' 9' ' ' ILE . 42.1 mm -47.75 -37.12 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.443 -0.786 . . . . 0.0 109.147 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -77.25 -52.31 9.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.378 -0.826 . . . . 0.0 109.142 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 11' ' ' PHE . 1.1 mm-40 -59.29 -42.88 92.31 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.271 -0.893 . . . . 0.0 109.043 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -46.6 -23.82 0.45 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.068 -1.02 . . . . 0.0 109.275 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 5' ' ' ILE . 4.1 mm -97.57 -15.74 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.827 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.4 OUTLIER -120.55 -52.11 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.106 -0.996 . . . . 0.0 108.589 179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.573 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -42.17 -32.36 0.47 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.6 -45.3 13.76 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.87 -32.02 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.436 -1.038 . . . . 0.0 108.824 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.5 -32.56 54.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.405 -0.809 . . . . 0.0 109.018 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.468 ' HB2' ' O ' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -62.48 -53.31 56.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -0.846 . . . . 0.0 108.861 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.0 -22.87 2.52 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -99.39 -17.17 18.13 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.466 -0.771 . . . . 0.0 109.267 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.93 -54.07 4.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 0.0 109.829 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.876 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -56.73 -25.26 54.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 110.02 -179.553 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -68.95 -45.0 71.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.188 -0.945 . . . . 0.0 109.957 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.17 -33.47 67.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.92 . . . . 0.0 109.834 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.7 t -74.67 -4.49 37.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 0.0 110.163 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 19' ' ' ARG . 61.3 t -107.83 -31.95 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.04 -1.037 . . . . 0.0 110.078 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.723 HD12 ' N ' ' A' ' 24' ' ' ILE . 2.4 mp -106.91 -17.0 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.052 -1.03 . . . . 0.0 109.777 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.64 94.04 2.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -0.956 . . . . 0.0 109.64 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.414 179.934 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.72 178.75 6.38 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.85 1.448 . . . . 0.0 110.183 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 52.77 45.31 60.83 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.556 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -82.26 -49.87 9.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -1.182 . . . . 0.0 109.395 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.556 ' N ' ' CG2' ' A' ' 4' ' ' THR . 22.2 mm -53.89 -40.02 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.431 -0.793 . . . . 0.0 109.655 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -61.82 -51.51 67.96 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.367 -0.833 . . . . 0.0 109.424 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.589 ' HG3' ' N ' ' A' ' 8' ' ' ASN . 0.8 OUTLIER -64.2 -29.74 70.83 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.192 -0.943 . . . . 0.0 109.175 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.589 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 1.8 t30 -63.57 -11.29 23.4 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.718 -1.238 . . . . 0.0 108.229 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 9' ' ' ILE . 39.6 mt -109.02 -8.65 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.462 -0.774 . . . . 0.0 109.861 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.511 HG22 ' HA ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -124.37 -42.99 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.555 ' N ' ' O ' ' A' ' 7' ' ' GLU . 13.8 t80 -45.11 -32.55 1.81 Allowed 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.029 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.82 -49.96 4.86 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.63 -35.23 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -1.179 . . . . 0.0 108.941 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -65.05 -45.47 85.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.359 -0.838 . . . . 0.0 109.113 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.474 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -57.64 -53.12 61.74 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.394 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 15' ' ' TYR . 1.5 m-20 -45.69 -30.8 1.68 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.01 -26.9 18.15 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.474 ' N ' ' O ' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -69.83 -44.7 69.42 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.56 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -69.06 -28.52 66.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 0.0 109.286 179.782 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -75.13 -12.02 60.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.3 -0.875 . . . . 0.0 109.324 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -100.85 -45.03 5.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.845 . . . . 0.0 109.432 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 48.0 t -71.77 -37.62 70.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 0.0 109.47 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 19' ' ' ARG . 73.1 t -63.02 -49.37 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.329 -0.857 . . . . 0.0 109.459 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.838 ' N ' HD12 ' A' ' 24' ' ' ILE . 2.7 mp -91.77 8.88 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.632 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 22' ' ' SER . 0.6 OUTLIER -49.91 147.42 3.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.572 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.069 -0.967 . . . . 0.0 109.469 -179.94 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 ttm . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 120.754 0.311 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.46 173.45 13.17 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.079 1.568 . . . . 0.0 110.561 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.44 67.34 1.77 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.54 -38.31 3.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.297 -1.12 . . . . 0.0 109.238 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.472 ' O ' HG13 ' A' ' 9' ' ' ILE . 34.2 mm -55.7 -46.89 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.312 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.436 ' HG3' ' N ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -60.99 -36.51 79.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.361 -0.837 . . . . 0.0 109.207 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 11' ' ' PHE . 2.1 mm-40 -70.17 -50.46 40.07 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.893 . . . . 0.0 108.963 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -48.16 -23.11 0.76 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 109.47 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 5' ' ' ILE . 18.2 mt -91.97 -13.36 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.302 -0.874 . . . . 0.0 109.866 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.55 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -119.07 -49.59 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.55 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -43.86 -36.28 2.3 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.57 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.99 -54.97 8.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.95 -47.34 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -61.6 -24.65 66.83 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.488 ' O ' ' N ' ' A' ' 18' ' ' TYR . 11.6 t80 -61.17 -57.72 11.29 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 15' ' ' TYR . 44.7 m-20 -45.36 -28.67 0.89 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -94.73 -26.18 16.38 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.526 ' N ' ' O ' ' A' ' 14' ' ' SER . 9.9 t80 -76.38 -41.22 48.73 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.876 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -45.6 -37.8 5.93 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.235 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.539 ' C ' ' CD1' ' A' ' 20' ' ' TYR . 1.5 t80 -68.49 -42.97 77.88 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 4.5 mtt85 -67.99 -27.44 66.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.452 -0.78 . . . . 0.0 109.362 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.4 t -79.87 -44.54 20.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.404 -0.81 . . . . 0.0 109.865 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 19' ' ' ARG . 42.1 t -57.87 -46.09 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.145 -0.972 . . . . 0.0 109.606 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.734 ' N ' HD12 ' A' ' 24' ' ' ILE . 3.2 mp -93.52 -13.22 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.906 . . . . 0.0 109.517 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.678 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 0.6 OUTLIER 42.38 84.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.745 179.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.678 ' HB3' ' O ' ' A' ' 25' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.524 179.88 . . . . . . . . 1 1 . 1 stop_ save_